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Cytokines are a group of protein cell regulators that are mainly 
produced by a wide variety of cell types, especially cells of the 
immune system. Recently, i t has been shown that cytokines can 
induce immune responses on the cells of central nervous system. 
Since cytokines play an important role in the communication 
between cells of the immune and nervous systems, i t is of 
considerable interest to study their effects on C6 glioma cells, which 
represent a good model system for studying the conditions and 
factors which regulate the proliferation and differentiation of glial 
cells and the signalling pathways that might be involved in these 
processes. 
Results of the present study indicated that cytokines such as 
TNF-a, IL- la , IL- lp and LIF stimulate PH]-thymidine incorporation 
in C6 cells, in a dose- and time-dependent manner. Not only D N A 
synthesis was increased but the growth of the C6 cells was also 
markedly enhanced by these cytokines. In addition, 
lipopolysaccharide (LPS), a well-known potent inducer of cytokine 
secretion, was found to induce significant proliferation in C6 cells. 
The present study demonstrated that both TNF-a- and LIF-
induced proliferation in C6 cells involve protein kinase C (PKC), Ca2+ 
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and tyrosine kinase. The involvement of PKC mediating the action of 
TNF-a was demonstrated by observations that potent PKC inhibitors, 
Ro31-8220, staurosporine and calphostin C, inhibited both the TNF-
a - and LIF-stimulated proliferation in C6 cells; whereas PKC 
activators, PMA and PDA, induced C6 cell proliferation. In addition, 
the proliferative effects of PMA and PDA were also blocked by the 
three PKC inhibitors tested. 
Since some PKC isoforms are calcium-dependent, the effects of 
A23187, a calcium ionophore, as well as some calcium channel 
blockers on cytokine-induced proliferation were investigated. A23187 
alone stimulated C6 cell proliferation; and in the presence of a sub-
optimal dose of cytokines such as TNF-a, IL- la , IL- ip and LIF, 
A23187 further enhanced the proliferation induced by these 
cytokines. The involvement of calcium in mediating the proliferative 
effects of TNF-a and LIF is further supported by observations that 
calcium channel bl0ckers-LaCl3, verampil and nifedipine, inhibited 
the proliferative effects of these two cytokines in a concentration-
dependent manner. In addition, EGTA, a Ca〗+ chelator, has similar 
inhibitory action on the cytokine-induced C6 cell proliferation. 
Since tyrosine kinase is a well known second messenger in 
cytokines function, its involvement in cell proliferation was also 
examined in this project. It was found that C6 cell proliferation 
induced by TNF-a and LIF was sensitive to the presence of selective 
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tyrosine kinase inhibitors, herbimycin A and tyrphostin, which could 
block the proliferative effects of PMA and PDA. 
In addition, the present study also showed that nitric oxide 
synthase inhibitors, NG-methyl-L-arginine and NW-nitro-L-arginine 
methyl ester, were capable of inhibiting the proliferative effect of 
TNF-a or LIF on C6 cells. On the other hand, the exogenous nitric 
oxide donor, sodium nitroprusside, did not show any proliferative 
effect on C6 glioma cells. Though the nitric oxide formation was 
induced by cytokines including TNF-a, LIF, I L - l a and IL- ip , the 
increase was much lower than the reported data. 
Finally, the involvement of cyclic nucleotides and p-adrenergic 
receptor in cytokine-induced C6 cell proliferation was also 
investigated. It was found that cyclic nucleotides, including dbcAMP 
and dbcGMP, and a p-adrenergic agonist, isoproterenol, significantly 
increased the proliferation of C6 cells. Likewise, propranolol, an 
antagonist of p-adrenergic receptor, was shown to reduce greatly the 
stimulatory effect of TNF-a or isoproterenol on PH]-thymidine 
incorporation in C6 cells at a concentration of 25 ^iM. The exact 
mechanism(s) by which cyclic nucleotides and P-adrenergic receptor 
might modulate C6 cell proliferation remains to be elucidated. 
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Chapter 1 Introduction 
Chapter 1 INTRODUCTION 
1.1 Cytokines in the Central Nervous System 
1.1.1 Basic Properties of Cytokines 
Cytokines are a group of protein cell regulators, which are 
produced by a wide variety of cells in response to various inducing 
stimuli, and may have effects on cells distant f rom the cells of origin. 
Addit ionally, they are defined as a class of inducible, water-soluble, 
heterogeneous proteinaceous mediators of animal origin w i th 
molecular weights greater than 5,000 that exercise specific, receptor-
mediated effects in target cells, or in mediator-producing cells 
themselves (Meager, 1990). 
Cytokines are usually subdivided into well-characterized 
classes including "growth factors", "colony stimulating factors 
(CSF)", "interleukins (IL)", "tumor necrosis factors (TNF) : 
"interferons (IFN)" and "chemotactic factors", etc. The properties of 
some major cytokines are given in Table 1.1. Cytokines may be 
considered to have hormone-like activities. Since they mostly exhibit 
direct mitogenic effect and act at short range in local cellular 
environments, they have been described as a new category of 
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intercellular mediators, even though, sometimes, they act at a 
distance when released into the blood. Secondly, they are pleiotropic 
mediators, which can act on many different cell types, or on cells of 
the same lineage at different stages of development. Moreover, 
cytokines can be produced by specialized and unspecialized cells of 
many tissues and organs, and their receptors are usually found on 
many cell types other than the predicted target cells. Furthermore, 
their biological activities are often highly overlapped. In brief, all the 
above properties of cytokines are different f rom those of hormones. 
Table 1.1 Properties of Some Major Cytokines* 
Cytokine No of MW(kD) Receptor Principal sources 
A. A. types 
TNF-a 157 51 55 kD/75 kD types macrophages 
(trimer) 
LIF 179 38-67 a-chain: 200 kD T lymphocytes; carcinoma 
p-chain: 130 kD cells 
(gpl30) 
IL-la 159 17.5 80 kD/68 kD types monocytes and many other 
cell types 
IL-ip 153 17.3 80 kD/68 kD types monocytes and many other 
cell types 
IL-6 184 21 a chain: 80 kD T lymphocytes; monocytes; 
P chain: 130 kD many other cell types 
* From Clemens, 1991; Nicola, 1994 and Pimentel, 1994. 
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Following receptor occupancy by cytokines, intracellular 
signaling pathways are activated to effect metabolic changes, gene 
induction, and structural alterations leading to proliferative, 
differentiating, or functional responses of the target cells. The genes 
coding for cytokines appear to be tightly regulated. A specific 
stimulus is usually required for induction or de-repression of 
cytokine genes. In many instances, a number of these substances and 
entities act by binding to the cell surface, in a way much resembling 
the binding of cytokines to their cell receptors, to stimulate cytokine 
synthesis. For example, part of the cell wal l of pathogenic Gram-
negative bacteria known as, lipopolysaccharide (LPS), binds to the 
cell surface of macrophages and induces the synthesis of a number of 
cytokines (Lee et aL, 1993b). 
I t is well-documented that cytokines have important roles in 
the growth, development, and maintenance of advanced 
multicellular, multi-organ species where the orderly assembly and 
function of cells is vital to normal morphogenesis, not only during 
embryogenesis and neonatal development but also through to 
adolescence and adulthood (Nicola, 1994). In addition, cytokines play 
a large number of physiological roles, such as control of host 
defenses against infections, cell proliferation and differentiation, 
regulate hematopoiesis, immune responses and inflammatory 
responses and fever, wound healing and tissue remodelling, and 
influence on cellular metabolism etc. (Clemens, 1991). 
3 
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1.1.2 The General Characteristics of Glial Cells 
The first account of neuroglia was cited by Dutrochet in 1824, 
who noticed the existence in the central nervous system (CNS) of 
non-neuronal components made up of spindle-shaped cells which 
were morphologically distinct f rom neurons (Virchow, 1860). These 
cells were considered as a form of connective tissue wi th in the CNS, 
and were called "neuroglia", which means nerve glue. There are two 
broad sub-groups of glial cells: the macroglia, which consists of 
astrocytes, oligodendrocytes and ependymal cells, and microglia. The 
basic properties of astrocytes, oligodendrocytes and microglia are 
described below. 
1.1.2.1 Astrocytes 
The astrocyte is the most abundant cell type in the CNS, 
outnumbering neurons by about 10:1. They are, in reality, a lineage 
representing a large family of cells that share certain biochemical and 
morphological specialization, while diverging in certain functional 
capabilities. Classically, there are two principal types of astrocytes, 
the protoplasmic (type-l) and fibrous (type-2) astrocytes, which are 
classified according to their morphological properties, antigenic 
phenotypes, kinetic development, appearance, and responses to the 
growth factors. The protoplasmic astrocytes are characterized by 
4 
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thick, branched processes wi th spiny projections and are localized 
primari ly w i th in the gray matter. The fibrous astrocytes, in contrast, 
consist of relatively long, thin processes wi th few branches and are 
the predominant type in the white matter. 
There are fundamentally three characteristic features that 
define astrocytes in the mammalian CNS. The most important is the 
cytoplasmic inclusion of 6- to 9-nm intermediate filaments whose 
major structural component is a 49-kD protein, the glial f ibri l lary 
acidic protein (GFAP) (Eng et al., 1971). The two other features are the 
presence of glycogen granules observed by electron microscopy 
(Revel et aL, 1960), and membrane-associated orthogonal-particle 
complexes by freeze-fracture studies. These complexes are strictly 
unique to astrocytes and are not found on myelin, neurons or other 
glial cells (Dermietzel, 1974). Recently, other biochemical markers in 
astrocytes are also found, such as glutamine synthetase (GS), the 
calcium binding protein, S-100, and glutathione-S-transferase subtype 
Yb (Cammer et al., 1989; Norenberg & Martinez-Hernandez, 1979; 
Waniewski & Martin, 1986). 
Along wi th the great variety of astrocyte types, there is an 
equal diversity of specified functions that can be ascribed to 
particular astrocytes based upon their positional relationships wi th in 
the neuraxia and some of them are listed in Table 1.2. 
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Table 1.2. Some Known Astrocyte Functions* 
1. Neuronal support 
2. Guidance for developing neurons 
3. Regulation of the extraceUular environment 
4. Synaptic encapsulation 
5. Regulation of synaptic modulation 
6. Participation in node of Ranvier formation 
7. Regulation of cerebral blood flow by K+ siphoning 
8. Liduction of blood-brain barrier properties in endothelial ceUs 
9. Scar formation and repair of CNS foUowing injury 
10. Response capabiKty to a variety of transmitters and peptides 
* From Frohman et al., 1989b. 
1.1.2.2 Oligodendrocytes 
Oligodendrocytes arise from the oligodendrocyte-type-2 (0-2A) 
progenitor cell. The function of the oligodendrocyte is to produce 
myelin. Myelin sheaths are cytoplasmic projections which extend 
from the oligodendrocyte cell body to wrap around nerve fibers in a 
spiral fashion. There are three kinds of oligodendrocyte-specific 
markers. The most common one is the galactocerebroside, which is 
unique to oligodendrocytes and is the major glycolipid of myelin 
(Raff et al., 1978). The other type of marker is the protein markers, 
which include myelin basic protein, proteolipid protein and myelin-
associated protein (Lees & Brostoff, 1984). Additionally, 
oligodendrocytes have several cell-specific enzymes, such as 2',3'-
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cyclic nucleotide 3'-phosphohydrolase (CNP) and glycerol-3-
phosphate dehydrogenase (de Vellis et aL, 1967; Drummond et aL, 
1962). 
1.1.2.3 Microglial 
Microglia constitute approximately 10% of the total glial cell 
population, which are considered as the resident macrophages of the 
brain (Benveniste, 1992b). According to their variable morphology, 
there are several major subtypes of microglia including ramified, 
ameboid and perivascular microglia. The major function of microglia 
is the phagocytosis of cellular debris (Perry & Gordon, 1988). 
Microglia can be identified by a number of cell markers, such as 
immunoglobulin Fc receptor (Perry et al., 1985), type 3 complement 
receptors (Giulian & Baker, 1986), P2-integrins (Akiyama & McGeer, 
1990), nonspecific esterase (Suckling et al., 1983) and lectin Ricinus 
communis agglutinin I (Mannoji et al" 1986). However, all these 
known phenotypic markers for microglia are shared wi th other cell 
types. 
1.1.3 The Effects of Cytokines on Neural Cells 
Cytokines, many of which have been discovered in studies of 
the hematopoietic system, are well known to regulate immune cell 
development and functions. Interestingly enough, a number of 
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cytokines, such as TNF-a, IL- la , IL- lp, IL-6 and LIF, have also been 
found to have the ability to regulate neural cell proliferation and gene 
expression. These cytokines are known to affect the survival, growth, 
and gene expression in various types of neurons and glial cells in 
culture (Bartfai & Schultzberg, 1993). Moreover, several of these 
cytokines are either normally expressed in the nervous system or are 
up-regulated in the central or peripheral nervous system after injury 
or in neurological disease (Merril l & Chen, 1991; Patterson, 1994). In 
view of the importance of these cytokines as signals in neuroimmune 
interactions, the basic characteristics of these cytokines and their 
modulatory effects on neuronal cells w i l l be further discussed in the 
fol lowing sections. 
1.1.3.1 TNF-a and Neural Cells 
TNF-a is a 17 kD protein produced by macrophage in response 
to a wide variety of stimuli including mitogens, cytokines, bacteria, 
viruses and parasites (Spriggs et aL, 1992). TNF-a has been shown to 
take part in altering vascular endothelial cell functions during 
inflammation. For instance, TNF-a enhances their permeability (Brett 
et al； 1989), induces their expression of adhesion molecules (Prober et 
al" 1986) and increases local adhesion of neutrophils, monocytes or 
lymphocytes to endothelial cell surfaces (Pohlman et al., 1986). TNF-a 
is known to stimulate other cell types to produce cytokines, including 
IL-1, IL-6 , CSFs and TNF-a itself (Aggarwal & Vilcek, 1992; Beutler, 
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1992). TNF-a can also regulate immune responses by modulating the 
expression of class I and I I major histocompatibility complex (MHC) 
molecules on a variety of cell types. TNF-a is also an endogenous 
pyrogen which acts on cells in the hypothalamic regions of the brain 
to induce fever (Beutler & Cerami, 1989). In addition,- TNF-a plays a 
role in mult iple sclerosis, and is involved in autoimmunity and in 
bacterial, parasitic, and viral infection (Beutler, 1992). 
TNF-a has been shown to mediate myelin damage in vitro 
(Selmaj & Raine, 1988), and has cytotoxic activity against rat 
oligodendrocytes, which results in cell death (Robbins et al., 1987). 
These observations suggest that TNF-a contributes to the 
demyelination process in neurological diseases. TNF-a also has 
multiple effects on astrocytes which are noncytotoxic in nature, and 
may function in an autocrine manner as astrocytes express specific 
high affinity TNF-a receptors (Benveniste et al., 1989), and secrete 
TNF-a upon activation by a variety of stimuli (Chung & Benveniste, 
1990; Lieberman et aL, 1989). Astrocytes also respond to TNF-a by 
secreting IL-6, granulocyte colony stimulating factor (G-CSF) and 
granulocyte/ macrophage colony stimulating factor (GM-CSF) 
(Benveniste et al； 1990; Frei et al； 1989; Malipiero et al, 1990). 
Additionally, mouse microglia produce TNF-a in response to LPS or 
IFN-y (Frei et al" 1987). In primary astrocytes, TNF-a increases class I 
MHC and intercellular adhesion molecule-1 (ICAM)-1 expression, 
and enhances class I I MHC expression induced by IFN-y or virus 
9 
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(Frohman et ah, 1989a; Massa et al, 1987). This indicates that astrocyte 
can function as an antigen presenting cell (APC) wi th in the CNS. 
TNF-a has a direct mitogenic effect on both primary astrocytes 
(Selmaj et al, 1990) and human astroglioma cell lines (Bethea et al, 
1990; Lachman et aL, 1987), which is thought to contribute to the 
reactive astrogliosis associated wi th various neurological diseases. 
On the other hand, TNF-a also targets on the neurons of 
hypothalamus in fever (Dinarello et al, 1986). In peripheral tissues, 
such as pancreatic cells, TNF-a has been shown to induce insulin 
secretion (Southern et al, 1990). These observations confirm the 
diverse functions of TNF-a in the body. 
1.1.3.2 LIF and Neural Cells 
LIF is a basic and heavily glycosylated monomeric protein 
whose molecular weight is about 32-62 K (Hilton, 1992). LIF has been 
shown to be involved in the regulation of proliferation, 
differentiation and other functions in a wide diversity of cell types 
(Kurzrock et al, 1991; Metcalf, 1991). Some examples are: 
hematopoietic stem cell growth and differentiation (Escary et al., 
1993), megakaryocyte maturation (Burstein et al” 1992) and 
embryonic tissue development (Conquet & Brulet, 1990). Also, LIF 
can induce the production of IL-6 or other acute phase proteins in the 
liver (Murray et al, 1990). Through the induction of a variety of 
cytokines, LIF can modulate inflammation, immune responses, and 
10 
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connective tissue metabolism, and can act as a pathogenetic mediator 
in different disease states (Villiger et aL, 1993). 
In the nervous system, LIF promotes the transition f rom 
noradrenergic to cholinergic function in cultured sympathetic 
neurons, concomitantly decreasing tyrosine hydroxylase activity and 
inducing the activity of choline acetyltransferase and vasoactive 
intestinal polypeptide (Murphy et al., 1991; Sendtner et al, 1990). 
Also, LIF affects the survival or differentiation of motor and sensory 
neurons (Murphy et al" 1991; Sendtner et al, 1990). When applied to 
peripheral nerves in vivo, this cytokine is retrogradely transported, 
and rescues damaged sensory neurons (Cheema et al., 1994; Hendry 
et al" 1992) as it does in cultured neurons (Murphy et al, 1993). LIF 
also alters the phenotype of sensory neurons in culture (Fan & Katz., 
1993; Nawa et al., 1990). There was evidence that LIF can be produced 
by glial cells in culture (Patterson & Chun, 1974; Shadiack et al； 1993). 
In addition, recombinant LIF can duplicate the effects of nerve injury 
in the induction of particular neuropeptides in sympathetic neurons 
(Jonakait, 1993; Patterson & Nawa., 1993; Sun et al., 1994). In the 
brain, LIF level rises after injury (Jonakait, 1993). Collectively, these 
results indicate that LIF production in the nervous system is induced 
by injury, and plays an important role in neuronal responses during 
injury. 
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1.1.3.3 IL-1 and Neural Cells 
IL-1 is a cytokine responsible for mediating a variety of 
processes in the host response to microbial and inflammatory 
diseases. There are two forms of IL-1, I L - l a and IL- ip , which are the 
products of two different genes (Pimentel, 1994). Al though these two 
forms of IL-1 have less than 30% structural homology to one another, 
they both bind to the same surface receptor, and have essentially 
identical biologic activities (Arai et al, 1990; de Giovine & Duff, 1990). 
IL-1 is the major co-stimulator for T-cell activation via the 
augmentation of both IL-2 and IL-2 receptor expression. These effects 
allow antigen-stimulated T cells to proliferate rapidly and expand in 
number. IL-1, in cooperation wi th other cytokines, enhance the 
growth and differentiation of B cells (Arai et aL, 1990; de Giovine & 
Duff, 1990). IL-1 is a principal participant in inflammatory reactions 
through its induction of other inflammatory metabolites, such as 
prostaglandin, collagenase, and phospholipase A2 (Arai et aL, 1990; 
de Giovine & Duff, 1990). Similar to TNF-a, IL-1 acts on endothelial 
cells to promote leukocyte adhesion and stimulates numerous cell 
types to produce various cytokines, such as IL-6, TNF-a, CSFs and 
IL-1 itself (Arai et al., 1990; de Giovine & Duff, 1990). 
IL-1 affects a wide range of target cells in the nervous system. 
Purified IL-1 was shown to have a stimulatory activity for astrocyte 
growth in vitro (Giulian & Lachman, 1985), and when injected into the 
12 
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brain, IL-1 can stimulate astrogliosis (Giulian et al" 1988a). 
Recombinant IL-1 has also been shown to stimulate the proliferation 
of a human astrocytoma cell line, U373, and to modulate gene 
expression in astrocytes (Lachman et al, 1987). Moreover, IL-1 can 
increase the expression of ICAM-1 adhesion molecule on human 
astrocytes (Frohman et al； 1989a). This is particularly important 
because the expression of ICAM can enhance the ability of an APC to 
present antigen when the number of MHC molecules on the cell 
surface is low. This suggests that the combined expression of I C A M 
and M H C may be synergistic in eliciting a more potent imrmme 
response (Demaine, 1989). 
IL-1 is also a potent inducer of other cytokine production in 
astrocytes. The stimulation of primary cultured rat astrocytes by IL-1 
results in the secretion of TNF-a (Chung & Benveniste, 1990) and IL-6 
(Benveniste et al., 1990; Frei et al； 1989), while in human astroglial cell 
lines CSFs (Tweardy et al., 1990), TNF-a (Bethea et al., 1991), and IL-6 
(Yasukawa et aL, 1987) are produced in response to IL-1. The 
production of IL-1 can be induced by LPS in C6 glioma cell line 
(Fontana et al,, 1982), murine astrocytes and microglia (Giulian et al, 
1986; Malipiero et al" 1990). Additionally, IL-1 acts as an autocrine 
stimulator of astrocytes, as they can secrete and respond to this 
cytokine. 
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In neurons, IL-1 has been shown to stimulate the synthesis of 
nerve growth factor (NGF) during peripheral nerve injury (Bartfai & 
Schultzberg, 1993; Berkenbosch et al" 1987). IL- lp mRNA has been 
detected in the rat hippocampal pyramidal cell layer (Bandtlow et al., 
1990), and IL-1 receptor is observed in the dentate gyrus of 
hippocampus in rat (Farrar et al, 1987) and mouse brains (Haour et 
al, 1990; Takao et al, 1990). Further studies on purif ied, 
homogeneous cell populations of neural crest origin, such as PC12 
cells, also support the claim that neuronal cell types may synthesize 
IL-1 (Alheim et al., 1991). These studies suggest that IL-1 is 
synthesized by neurons. 
The effects of IL-1 on the neuroendocrine system include 
regulation of corticosterone and gonadal hormone production, 
induction of slow-wave sleep, fever, corticotrophin-releasing factor 
and gastric acid secretion (Bartfai & Schultzberg, 1993). 
1.1.3.4 IL-6 and Neural Cells 
IL-6, along wi th IL-1 and TNF-a, are pleiotropic cytokines 
involved in the regulation of inflammatory and immunologic 
responses (Kishimoto, 1989). IL-6, a 26 kD molecule, is secreted by a 
wide range of cells. Depending on the cell types, the synthesis of IL-6 
is induced by a variety of agents, including the cytokines IL-1, TNF-a 
and IFN-y (Le & Vilcek, 1989). The two better known actions of IL-6 
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are on hepatocytes and B cells. In these cells, IL-6 can stimulate 
hepatocytes to produce several plasma proteins, such as fibrinogen 
and C-reactive protein, which contribute to the acute phase response 
(van Snick, 1990). In the immune system, IL-6 is the principal 
cytokine for inducing terminal differentiation of activated B cells into 
immunoglobulin-secreting plasma cells (van Snick, 1990). A minor 
function of IL-6 is as co-stimulator of T cells and thymocytes (van 
Snick, 1990). 
IL-6 has been demonstrated to have multiple effects on 
astrocytes, and functions in an autocrine manner as astroglioma is 
found to express specific high-affinity receptors for IL-6 (Taga et aL, 
1987). There are two endogenous CNS sources for IL-6, the astrocyte 
and microglia. Primary rat and murine astrocytes can secrete IL-6 in 
response to a variety of stimuli including virus, IL-1, TNF-a, IFN-y 
plus IL-1, LPS and calcium ionophore (Benveniste et al., 1990; Frei et 
aL, 1989; Lieberman et ah, 1989), while transformed microglia clones 
also produce IL-6 (Rigi et al； 1989). IL-6 has direct mitogenic effect on 
astrocytes (Selmaj et al., 1990) and the astrocytes secrete nerve growth 
factor in response to IL-6, which induces neural differentiation (Frei 
et al, 1989). IL-6 has been found to induce the differentiation of PC 12 
cells, as wel l as to increase the number of voltage-dependent Na+ 
channel (Satoh et al； 1988). Moreover, IL-6 has also been shown to 
inhibit TNF-a production by monocytes (Aderka et al., 1989). As 
astrocytes can secrete TNF-a, and TNF-a induces IL-6 production by 
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astrocytes, this may represent a negative regulatory pathway for 
controlling TNF-a expression in the CNS. 
In addition to the above effects on differentiation and cytokine 
production, IL-6 has many actions on the pituitary gland, such as 
stimulation of ACTH, gonadotropins and prolactin release (Naitoh et 
aL, 1988). Recently, i t has been shown that IL- lp induced an increased 
release of IL-6 f rom cultured rat anterior pituitary (Yamaguchi et al" 
1990). 
1.1.4 Immune Responses in the Central Nervous System 
From the above discussion, it is clear that cytokines play an 
important role in inducing immune responses on the cells of the 
central nervous system. However, the CNS has traditionally been 
considered as an "immunologically privileged site" for three major 
reasons. Firstly, the CNS lacks for the most part a lymphatic system 
that drains the tissues and captures potential antigens. Secondly, the 
CNS is protected from the blood by the blood-brain barrier (BBB), 
which is basically impermeable to many soluble substances, 
including cytokines, and restricts the migration of lymphoid cells into 
CNS. Lastly, the cells of the CNS express very low levels of antigens 
encoded by the MHC genes, whose products play a fundamental role 
in the induction and regulation of immune response (Booss et aL, 
1983; Peters et al., 1976; Wong et al； 1984). 
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Despite the above observation, recent work has shown that T 
cells in very low numbers are found wi th in normal brain tissue, and 
also in normal cerebrospinal fluid (Booss et al, 1983). However, the 
presence of lymphatic-like capillaries in the brain provides a possible 
natural, untraumatized, route for lymphoid cells into the CNS 
(Prineas, 1979). Another evidence is that pathological events wi th in 
the CNS often result in a breakdown of BBB, which permits cells of 
the peripheral immune system to enter this site. During human CNS 
diseases, such as viral encephalitis (Prineas, 1979), multiple sclerosis 
(Hauser et al, 1983, Prineas & Wright, 1978; Traugott et al, 1983), 
AIDS dementia complex (Navia et al, 1989) and animal models of 
CNS diseases, such as experimental allergic encephalomyelitis (EAE), 
inflammatory infiltrates composed of activated T cells, B cells, and 
macrophages are found in the brain. Furthermore, glial cells, 
especially astrocytes, can secrete immunoregulatory molecules that 
influence immune cells, as well as the glial cells themselves. Table 1.3 
shows the involvement of some cytokines in various diseases in the 
brain (Morganti-Kossmann et al., 1992; Pimental, 1994). Thus, 
astrocytes, which have been demonstrated to act as intracerebral 
antigen presenting cells (Frohman et al" 1989b), may play a crucial 
role in the immune response in the CNS via soluble cytokines. 
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Table 1.3 Cytokines and Neuropathogenesis* 
Cytokine Disease/Infection Probable Sources 
IL-1 multiple sclerosis, macrophages, microgUa, 
Alzheimer's disease injury astrocytes 
TNF-a multiple sclerosis, bacterial macrophages, 
meningitis, HW, injury astrocytes 
TNF"P multiple sclerosis, T lymphocytes 
microgUa, astrocytes 
IL-6 viral or bacterial meningitis, macrophages, microgUa, 
HIV, meningoencephaUtis, injury astrocytes 
IFN-y multiple sclerosis, lymphocytes 
TGF"P HIV, cytomegalovirus macrophages, microgUa, 
astrocytes 
* From Morganti-Kossmann et al., 1992; Pimental, 1994. 
Although brain cells do not constitutively express class I I M H C 
antigens, IFN-y and TNF-a can induce the expression of these 
molecules in astrocytes and microglia (Fierz et al., 1985; Fontana et al., 
1984; Pulver et al； 1987; Suzumura et al, 1987). Furthermore, viral 
infections, such as hepatitis and measles virus infection, also result in 
class I I M H C antigen expression in the CNS (Massa & ter Meulen, 
1987; Massa et al； 1986). Like astrocytes, endothelial cells can produce 
class I I M H C antigens upon treatment w i th IFN-y (Male et al, 1987; 
Pober et al, 1983), and ICAM-1 is also presented on vascular 
endothelial cells and fibroblasts upon the stimulation w i th cytokines, 
such as IFN-y, IL-1 and TNF-a etc. (Dustin et al, 1986). After 
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induction, class I I MHC and ICAM-1 positive endothelial cells could 
then act as the first APC encountered by blood-borne T cells, 
resulting in activation of these cells (Figure 1.1). These activated T 
cells wou ld then be able to penetrate the BBB in a variety of fashions, 
such as passing through altered tight junctions- between the 
endothelial cells, or dissolving the extracellular matrix produced by 
endothelial cells (Frohman, 1989b; Merril l, 1987). Activated T cells 
have been shown to secrete an endoglycosidase that digests the 
proteoglycans of the extracellular matrix (Naparstek et al., 1984). 
Once in the brain, activated T cells release cytokines along w i th 
entering macrophages. These cytokines could exert a potent influence 
on astrocytes, thus creating an environment for local immune 
responses wi th in the CNS. Additionally, astrocytes, 
oligodendrocytes, and microglia have been shown to constitutively 
express low levels of class I antigens (Wong et al., 1984), which could 
be increased by cytokines, including IFN-y, in a wide variety of 
species (rat, mouse and human) (Hirayama et al., 1986; Suzumura et 
aL, 1986). The enhanced class I MHC antigen expression implicates 
that they can be rendered susceptible to lysis by class !-restricted 
cytotoxic T cells. In fact astrocytes were shown to serve as targets for 
class I MHC-restricted cytotoxic T cells in vitro (Skias et al., 1985). 
The subsequent immune response in the CNS is summarized in 
Figure 1.1. The proliferation of astrocytes is induced by TNF-a and 
IFN-y from T cells, and IL-1 produced by astrocytes themselves. IL-2, 
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Figure 1.1 The blood T cells penetrate the BBB and initiate the 
immune response in the central nervous system. (Modified f rom 
Frohman, 1989b and Merril l, 1987). 
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produced by activated T cells, is specific for oligodendrocytes and 
induces their proliferation. In contrast, brain macrophages could 
cause demyelination. The further immune reactions result in 
inflammation, demyelination or remyelination, plaque formation etc., 
which are usually observed in the brain diseases (Merrill, 1987). 
1.2 The C6 Glioma As a Model for the Study of Glial Cell 
Growth and Differentiation 
1.2.1 The Rat C6 Glioma Cells 
The term glioma describes the group of glial neoplasms 
including astrocytoma, glioblastoma, ependynoma, 
oligodendroglioma and mixed gliomas, such as oligoastrocytoma. 
Astrocytic gliomas, which contain fibrillary neoplastic cells, are the 
most common gliomas. Glioma cells are particularly easy to grow in 
tissue culture, thus in unselected material about 20 % of glioblastoma 
mult i form cells can be grown as continuous cell lines (Westermark et 
al., 1973). Although they may not be true representatives in all 
aspects of glioma or glial cells in vivo, the relative ease wi th which 
such cell lines can be established has made them widely used as 
model system for studies on the biology of glioma or glial cells. A 
number of rat brain tumors induced by N-nitrosomethylurea and 
consisting of more or less differentiated astrocyte-like cells are found 
to contain S-100 protein, a characteristic protein of glial cells. It was 
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shown that injection of newborn rats wi th these cultured tumor cells 
resulted in a high efficiency of tumor formation (Benda et al, 1968). 
Five morphologically distinct clonal cell strains were established 
f rom these tumors, only one contains appreciable amounts of S-100, 
and this is the C6 glioma cell line (Benda et al, 1968 ) . . 
C6 glioma cells have provided a useful model to study glial cell 
properties, glial factors and sensitivity of glial cells to various 
substances and conditions. As a k ind of transformed cell line, the 
growth characteristics of C6 cells are immortal, anchorage 
independent, loss of contact inhibition, high plating efficiency and 
shorter population doubling time. In addition to its homogeneous 
genetic properties, C6 cells are tumorigenic and angiogenic 
(Freshney, 1987). On the other hand, C6 cells express several glial-
specific markers such as S-100, GFAP and GS, the markers for 
astrocytes, and CNP, an enzyme marker for oligodendrocytes, have 
been proved to be expressed in the C6 cell line (Kempski et al, 1992; 
Vernadakis et al, 1992). Additionally, the expression or activity of 
these markers in C6 cells could be induced. For instance, CNP is 
induced by neuron-derived factors, epidermal growth factor and 
fibroblast growth factor, whereas GFAP and GS are induced by 
insulin, cyclic AMP, platelet-activating factor, muscle-derived factors, 
chronic p-receptor activation and IL-4 (Brodie & Goldreich, 1994; 
Brodie & Vernadakis, 1991; Parker et al" 1980; Vernadakis et al, 1991). 
Interestingly, cytokines are known to be involved in the expression of 
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astrocytic and oligodendrocytic properties expression in C6 cells of 
early passages (Brodie & Goldreich, 1994). 
C6 glioma cells have been found to respond to several 
cytokines, such as TNF-a, IL-6, IFN-y and IL-4. The growth of C6 
glioma cells is stimulated by TNF-a, IL-6 and IFN-y (Munoz-
Fernandez et al, 1991; Munoz-Fernandez & Fresno, 1993). In addition, 
IL-4 exerts a biphasic effect on C6 cell proliferation, increasing cell 
proliferation at concentrations ranging from 10-50 ng /m l , and 
inhibit ing at higher concentrations (Brodie & Goldreich, 1994). The 
inhibit ion of cell proliferation is associated wi th differentiation of the 
cells to express astrocytic phenotypes as evidenced by morphology, 
increased GFAP immunoreactivity and elevated GS expression 
(Brodie & Goldreich, 1994). IL-4 also induced the secretion of nerve 
growth factor by C6 glioma cells (Brodie & Goldreich, 1994). These 
results suggest that the C6 cell line represents a good cell model for 
the study of the proliferation and differentiation of glial cells in vitro, 
1.2.2 The Differentiation and Proliferation of C6 Glioma Cells 
It is well-known that the starting point for the cellular analysis 
of glial development was the optic nerve, the simplest part of the 
CNS (Figure 1.2). The first glial cell type to appear in the optic nerve 
during embryonic development is the type-1 astrocyte. The next two 
/ 
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Figure 1.2 The development of glia and C6 glioma cell line (Modified 
f rom Linskey & Gilbert, 1995 and Vernadakis et al, 1991). 
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glial cell types, type-2 astrocyte and oligodendrocyte, which appear 
during development of the rat optic nerve, are both derived f rom a 
single progenitor cell, the oligodendrocyte-type-2 astrocyte (0-2A) 
progenitor cell (Raff et al, 1983), which migrates into the optic nerve 
f rom the optic chiasm during embryogenesis (Small et al" 1987). In 
vitro studies suggest strongly that division of the 0 -2A progenitor 
cells is promoted by the type-1 astrocytes derived f rom the optic 
stalk, through the secretion of platelet-derived growth factor (Noble 
& Murray, 1984; Raff et al., 1988). 0 -2A progenitors give rise to either 
type 2 astrocytes or oligodendrocytes, depending on the 
environmental influence. In vitro experiments have shown that the 〇-
2A progenitor cell, in the presence of fetal calf serum, differentiates 
into a type 2 astrocyte, and in the absence of serum, into an 
oligodendrocyte. Another member of the 0 -2A lineage is the 0 -2A 
adult progenitor cell, which differs from its perinatal counterpart in 
many aspects, including antigen expression, morphology, cell-cycle 
length, motil ity, time-course of differentiation, in the manner in 
which i t generates astrocytes and oligodendrocytes and seemingly 
also in its capacity for extended self-renewal (Wolswijk & Noble, 
1989). 
The influence of mitogenic factors and cytokines on macroglia 
development have also been studied. Mitogenic brain extracts f rom 
embryonic days 16-18 brain were found to induce a 4-fold increase in 
neonatal astrocytes in vitro (Morrison et al； 1982). The astroglial 
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proliferation is due to the peptides released f rom ameboid microglia 
which act as glial promoting factors (Giulian, 1984; Giulian & Baker, 
1985). One of these factors is IL-1, which is produced by ameboid 
microglia f rom rat cerebral and cerebellar cortex derived f rom the 
late embryonic period (Giulian et al., 1986; Gordon & Hirsch, 1981). 
Thus, clusters of ameboid microglia found along growing axons in 
fetal corpus callosum may stimulate astroglial pathways which in 
turn determine the direction of axonal growth (Giulian et aL, 1988 a 
and b). Since this occurs during the critical developmental periods 
involving glial cell appearance, i t has been suggested that substance 
P (SP), a neuro-transmitter, may play a role in cytokine production 
and maturation of glial and neuronal elements (Charnay et al., 1983; 
Nomura et aL, 1982). Indeed, SP has been shown to stimulate 
astrocytes to produce IL-1, TNF-a and IL-6 (Kimball et aL, 1988; Lotz 
et aL, 1988). Conversely, IL-1 has also been demonstrated to induce 
SP production in sympathetic ganglia (Jonakait & Schotland, 1990). 
Thus, SP may influence glial cells during development in an 
autocrine loop involving various cytokines. In addition, several 
cytokines including IL-1 and TNF-a, as mentioned before, have 
effects on the proliferation and differentiation of glial cells. Since IL-1 
and TNF-a are capable of co-inducing each other and that astrocytes 
produce IL-1 and TNF-a, both autocrine and paracrine events ensure 
proliferation and activation of astrocytes during development. 
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Early passage C6 glioma cells express the properties of the 
progenitor glial cells. Since they are GFAP, GS and CNP positive, C6 
glioma cells have the properties of both astrocyte and 
oligodendrocyte. It has also been reported that C6 glioma cells 
exhibited differential enzyme expression wi th cell passage: the 
activity of CNP, an enzyme marker for oligodendrocytes, was 
markedly high and that of GS, an enzyme marker for astrocytes, was 
low in early passages (up to passage 26). However, this relationship 
was reversed in the late passages (beyond passage 70) (Parker et al； 
1980). In addition, early-passage cells express low level of GFAP 
immunoreactivity in contrast to late passage cells which express a 
high intensity of immunoreactive staining (Brodie & Vernadakis, 
1991). These observations suggest that C6 glioma cells, as a 
bipotential progenitor, may give rise to oligodendrocytes at the early 
passages and to astrocytes at the later passages (Vernadakis et al； 
1991). 
As mentioned before, a number of factors, such as insulin, 
cyclic AMP, platelet-activating factor, muscle-derived factors, 
transferrin and IL-4, can induce C6 cells to generate astrocytic 
phenotypes. On the other hand, factors including neuronal-derived 
factors, epidermal growth factor, fibroblast growth factor and 
platelet-derived growth factor can trigger the C6 cells to give rise to 
oligodendrocytic phenotypes (Figure 1.2). It has been known that 
many of these inducible factors, such as growth factors and 
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interleukins, are also involved in the inflammation and immune 
response in the CNS. These findings clearly indicate that various 
microenvironmental factors, including cytokines, play a prominent 
role in influencing the glial phenotypes of C6 glioma cells. 
1.3 Signal Transduction Pathways in Cytokine-stimulated 
Glial Cells 
1.3.1 Intracellular Signalling Pathways of Cytokines 
Cytokines transmit their biological signals to responsive cells 
by interaction wi th specific high-affinity cell surface receptors. 
However, there is still relatively little knowledge of the mechanisms 
by which cytokines transmit signals via their receptors. At present, at 
least two signal-transmitting or activation pathways have been 
described that appear to be related directly to cytokine-mediated 
cellular response. One of these involves the calcium-binding protein 
calmodulin, guanine nucleotide-binding proteins (G-protein), and the 
enzymes adenylate cyclase and protein kinase A. In the other 
activation pathway, the receptor molecules themselves contain a 
tyrosine kinase which, when activated, subsequently activates 
phospholipases, possibly also through G-protein intermediates. The 
latter are responsible for the breakdown of plasma membrane inositol 
phospholipids to inositol triphosphate and diacylglycerol (DAG) 
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protein kinase C activation respectively (Meager, 1990). In fact, 
several mechanisms are involved in cytokine-triggered cell-specific 
responses. Among them, protein kinase C, tyrosine kinase, cyclic 
nucleotides and nitric oxide are highlighted here. 
1.3.1.1 Protein Kinase C Pathway 
Protein kinase C (PKC) comprises a family of related enzymes, 
which are a, Pi, Pii, y, 8, 8, X, ^ and 0. They possess regulatory and 
catalytic domains, wi th a site between them that is susceptible to 
proteolytic cleavage (Coussens et aL, 1986). Each molecule contains 
both conserved and variable sequence: C1-C4 are regions of conserved 
amino acids, V1-V5 are variable regions (Coussens et al., 1986). Protein 
kinase C can be divided into two main groups: the Ca2+-dependent, 
or conventional PKCs (cPKCs) and the Ca2+-independent, or novel 
PKCs (nPKCs). The PKC isoforms a, Pi, Pii and y, belong to the Ca?+-
dependent group, while the isoforms 5, s, X, ^ and 0，in which the C2 
conserved sequence is absent, belong to the Ca^^-independent group 
(Hug & Sarre, 1993). 
For the cPKCs, a model of activation was sufficient and 
convincing. It includes (1) the generation of diacylglycerol and 
inositol 1,4,5-triphosphate from plasma membrane-associated 
phosphatidylinositol 4,5-bisphosphate by the action of phospholipase 
C, (2) the release of Ca2+ from intracellular storage sites stimulated by 
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inositol 1,4/5-triphosphate, (3) the binding of Ca2+ to the Ci conserved 
region of PKC and subsequent translocation of the enzyme to the 
plasma membrane where i t is activated, via its Ci conserved region, 
by diacylglycerol and phosphatidyserine (PtdSer), the latter being 
constitutively present in the membrane (Bell &• Bum, 1991; 
Zidovetzki & Lester, 1992). In this model, phorbol ester, such as 
phorbol 12-myristate 13-acetate (PMA) and phorbol-12,13-diacetate 
(PDA), would mimic the action of DAG by their persistence in the 
cellular membrane, leading to a long-term activation of PKC 
(Gschwendt et aL, 1991). On the other hand, members of the nPKC 
group do not require Ca〗+ for activation, but require either 
DAG/PtdSer, or PMA/PtdSer (Lee & Bell., 1991). 
Cytokines, such as IFN-a, IL-1 and IL-3, have been reported to 
induce phosphatidylcholine hydrolysis (Cataldi et al., 1990). The 
selective activation of PKC p and 8 by IFN-a treatment of HeLa and 
Daudi cells respectively, have been demonstrated (Pfeffer et al, 1990, 
1991). The activated PKC can alter the phosphorylation of proteins, 
which could trigger the further intracellular biological function. 
1.3.1.2 Tyrosine Kinase Pathway 
Cell proliferation appears to be regulated by the tyrosine 
kinases which phosphorylate tyrosines in specific protein substrates 
(Ullrich & Schlessinger, 1990). The stimulation of various cell types 
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by IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, GM-CSF, erythropoietin (EPO) and 
ciliary neurotrophic factor (CNTF) has been shown to activate 
intracellular tyrosine kinases (Taga & Kishimoto, 1992). This kinase 
family includes Src, Ty2, JAK1 and JAK2 (Stahl & Yancopouls, 1993). 
Several cellular tyrosine kinases are also receptors for growth factors 
or cytokines, such as insulin-like growth factor-I, epidermal growth 
factor and macrophage colony stimulating factor (Aderem, 1993; 
Kishimoto et al., 1994). In addition, some cytoplasmic tyrosine kinases 
that do not require ligand binding for activation are nevertheless 
often associated wi th the plasma membrane or cytokeleton of the cell 
(Eiseman & Bolen, 1990). Cytokine receptors themselves that do not 
possess kinase activity might regulate activity of associated non-
receptor kinases. For example, the IL-3 receptor has no tyrosine 
kinase activity, but binding of IL-3 to sensitive cells causes increased 
tyrosine phosphorylation of several proteins (Linnekin & Farrer, 
1990). One recent evidence showed that JAK2, a nonreceptor type 
tyrosine kinase, might be activated by this cytokine (Silvennoinen et 
aL, 1993). The protein substrates for tyrosine kinases have not been 
well defined. Often, the enzymes themselves become phosphorylated 
on one or more tyrosine residues, and cytokines receptors are often 
auto-phosphorylated after the binding of their ligands (Weiss & 
Littman, 1994). Thus, tyrosine phosphorylation may be the first event 
in a cascade of reactions leading to the many biological effects of the 
cytokine, as demonstrated for the insulin, IGF-I, platelet-derived 
growth factor (PDGF) and M-CSF receptors (Weiss & Littman, 1994). 
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1.3.1.3 Cyclic Nucleotide Pathway 
The best characterized second messenger system in mammalian 
cells is the well-known adenylate cyclase / adenosine 3',5' 
monophosphate (cAMP) pathway. cAMP-dependent protein kinase 
mediates a wide variety of serine/ threonine-specific protein 
phosphorylation events, directly or indirectly (Clemens, 1991). The 
wide range of cAMP-dependent protein kinase substrates explains 
why ligands that activate or inhibit adenylate cyclase have diverse 
effects, and is perhaps a precedent for understanding the multiple 
effects of other cytokines that use alternative pathways. Surprisingly, 
few cytokines appear to act directly through cAMP as a second 
messenger. Conversely, cAMP-dependent protein kinase can 
phosphorylate and regulate proteins involved in other signal 
transduction mechanisms. On the other hand, cyclic guanosine 3。5, 
monophosphate (cGMP) has a much more restricted second 
messenger role than cAMP. It is synthesized by guanylate cyclase 
and removed by phosphodiesterase-catalyzed hydrolysis to 5'GMP. 
As yet there are only a few reports suggesting possible involvement 
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1.3.1.4 Nitr ic Oxide Pathway 
Nitr ic oxide (NO), a vascular and neuronal messenger and a 
cytotoxic and cytostatic agent, is synthesized f rom L-arginine by the 
enzyme nitric oxide synthase (NOS). Although mult iple subtypes of 
NOS have been reported, they can be classified into two main 
categories (Nathan, 1992). One type of NOS is constitutively 
expressed in several cell types including neurons and endothelium, 
and can be activated by the reversible binding of calmodulin in a 
Ca2+-dependent manner. The activity of the second type, whose 
expression can be induced in several cell types, including 
macrophages, hepatocytes, neutrophils, endothelial cells and 
astrocytes, is independent of Ca〗+ and once expressed can be active 
for extended intervals. The latter one is described as inducible NOS 
(iNOS). This isoform requires NADPH and tetrahydrobiopterin as 
cofactors as wel l as flavoproteins. iNOS expression in nervous tissues 
can be induced not only by LPS but also by various cytokines, such as 
IFN-y, IL- ip and TNF-a, alone or in combination (Hartung et al" 1992; 
Ki lbourn & Belloni, 1990). 
A major action of NO is to stimulate soluble guanylate cyclase; 
in the CNS this would elevate cGMP levels in presynaptic nerve 
endings and glial cells. Cyclic GMP has been shown to decrease free 
calcium level wi th in cells, possibly owing to stimulation of the 
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formation of inositol phosphates evoked by agonists, perhaps by 
interaction w i th a G-protein (Hirata et al； 1990). In astrocytes, i t has 
been shown that agonists evoke inositol phosphates formation and 
induce calcium fluxes (McCarthy & Salm, 1991), thus NO-induced 
increases in cGMP level may serve to modulate these events. In this 
connection, i t is interesting to note that nitric oxide has been shown 
to be involved in cytokine-induced growth of glial cells (Munoz-
Fernandez & Fresno, 1993). These observations may indicate that NO 
associated w i th cGMP is seemingly both an intercellular messenger 
and a regulatory molecule in glial cells. 
1.3.2 Intracellular Signalling Pathways in Cytokine-stimulated C6 
glioma cells 
There has been an increasing interest in the studies of the 
biological effects of cytokines on astrocytes and the possible 
signalling pathways that are involved. For example, IL- lp alone can 
induce NO production in astrocytes (Lee et aL, 1993a). However, NO 
production was markedly enhanced when the astrocytes were co-
stimulated wi th IFN-y and TNF-a (Lee et al, 1993a). On the other 
hand, the NO releasing compound sodium nitroprusside (SNP) 
down-regulates, in a concentration-dependent manner, the IFN-y-
induced MHC II expression on astrocytes (Heuschling, 1995). It is 
known that C6 glioma cells can respond to the induction of cytokines 
including TNF-a, IFN-y, IL-6 and IL-4 (Munoz-Fernandez et al； 1991; 
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Munoz-Fernandez & Fresno, 1993). These indicate that similar 
signalling pathways may be triggered in cytokine-induced C6 glioma 
cells. 
Similar to astrocytes, nitric oxide associated cGMP increase is 
found to act as a signal transducer in C6 glioma cells (Simmons & 
Murphy, 1993; Vigne et al, 1993). It has been observed that C6 cells 
treated w i th LPS or LPS plus TNF-a show Ca2+-independent and L-
arginine-dependent NOS activity. The NOS induction may be 
dependent on new protein synthesis. In the presence of cofactors, 
such as NADPH, L-arginine and Ca〗+ etc., the activated NOS could 
result in the increase in level of cGMP in C6 cells (Simmons & 
Murphy, 1992) and primary rat glial cultures (Galea et al" 1992). On 
the other hand, cGMP production is significantly decreased by IL-4, 
IL-10 or transforming growth factor (TGF)-Pi (Demerle-Pallardy et al； 
1993; Simmons & Murphy, 1993). One hypothesis regarding the 
mechanism of LPS induction is that i t causes these cells to release 
cytokines which induce the enzyme directly. As expected, IFN-y, IL-
1P and TNF-a can induce L-arginine-dependent cGMP synthesis in 
C6 glioma cells whereas TGF-Pi non-specifically decreased the 
induction (Simmons & Murphy, 1993). The observation that TNF-a, 
IFN-y, and/or IL- lp and LPS plus TNF-a or IFN-y increased NO 
production has supported the role of NO as a signal transducer 
triggered by cytokines in astroglial cells (Feinstein et ah, 1994b; Galea 
et al, 1992). Moreover, NO is also likely to be involved in the 
1 
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cytokine-induced growth of C6 cells, including TNF-a and IFN-y 
(Munoz-Fernandez & Fresno, 1993). 
The involvement of tyrosine kinase as a second messenger for 
the NOS production by C6 glioma has also been reported. Genistein 
and tyrphostin, the two selective inhibitors of tyrosine kinase 
(Akiyama et al, 1987; Holen et al, 1995), have been shown to prevent 
both LPS and cytokine-induced NOS activity in a dose-dependent 
manner (Feinstein et al； 1994a). The results suggest that NOS 
induction in C6 glioma cells is tyrosine kinase dependent. I t means 
that tyrosine kinase activation might be an upstream signal. 
Significant PKC activity has been demonstrated in rat C6 
glioma cells which correlated wi th the proliferation rate of the cells. 
Also, PKC can act as a kind of second messenger in A172, a human 
glioma cell line (Couldwell et al, 1992). Furthermore, a PKC inhibitor, 
H-9, inhibited the TNF-a- and IFN-y-induced C6 cell proliferation 
(Munoz-Fernandez & Fresno, 1993). These findings strongly suggest 
that activation of PKC is a potential common signal transduction 
mechanism induced by cytokines on glioma cells. 
Besides the above mentioned signal transducer molecules, the 
existence of other signalling pathways, including cAMP, Pi-
adrenergic receptor and phospholipase A2, is also found in the C6 
glioma cells. GFAP expression on C6 cells is induced by the addition 
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of dibutyryl cyclic adenosine monophosphate (dbcAMP), which can 
linearly increase the intracellular cAMP level. The result indicates 
that GFAP synthesis is regulated at the transcription level and that a 
cAMP-dependent mechanism determines its ultimate synthesis 
(Messens & Slegers, 1992). In addition, exposure of rat C6 glioma 
cells to either agonists or agents that increase cAMP levels leads to 
down-regulation of Pi-adrenergic receptor (Hosoda et aL, 1994). The 
regulation of pi-adrenergic receptor mRNA occurs at the level of 
gene transcription and by the induction of a repressor of the Pi-
adrenergic receptor gene (Hosoda et al., 1994). More recently, i t has 
been reported that treatment of the rat C6 glioma cell line w i th IL- ip 
resulted in an accumulation of cytosolic phospholipase A2 mRNA 
(Ozaki et aL, 1994). Nevertheless, whether pi-adrenergic receptor and 
phospholipase A2 are directly involved in the cytokine-induced 
signal cascades has yet to be determined. 
1.4 The Aims of This Project 
Cytokines are a heterogeneous group of polypeptide mediators 
that have been associated classically wi th the activation of the 
immune system and inflammatory response. An increasing number 
of related mediators have been shown to act on a variety of cell types, 
including cells of the nervous system. As reviewed in the previous 
sections, i t is clear that the cells of immune system and CNS can have 
similar functions: secretion of immunoregulatory cytokines, response 
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to cytokines and antigen presentation. The activation of astrocytes 
and microglia may contribute to either the init iation and/or 
propagation of intracerebral immune response. Recently, several 
lines of evidence show that cytokines, such as IL-1, IL-6, IFN-y and 
TNF-a, are implicated as signals in neuroimmune interactions 
(Blalock, 1994; Roszman & Brooks, 1992). It is well-known that the 
cells of the CNS, particularly the glial cells, are modulated by various 
cytokines. However, little is known about the cellular and molecular 
mechanisms involved in the cytokine modulation of various neuronal 
cell types. To understand better the relationship and communication 
between the immune system and the nervous system, i t is important 
to study the modulatory effects of various cytokines and their 
interactions in regulating the growth and differentiation of cells of 
the CNS. In addition, the elucidation of the nature of the second 
messenger signals involved in neuroimmune interactions can 
provide better insights into the molecular and cellular actions of 
cytokines in the CNS. 
Although cytokines such as TNF-a and IFN-y can induce glial 
cell proliferation and differentiation in vitro (Benveniste et ah, 1991; 
Selmaj et al； 1990), whether or not these cytokines can interact wi th 
one another and the signalling pathways mediating the activities of 
these cytokines in glial cells remain to be established. Because of the 
homogeneity of the C6 glioma cells and their known responsiveness 
to various cytokines, they were used as a model to study the 
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modulatory effects of cytokines on the proliferation and 
differentiation of glial cells in vitro. In this project, cell proliferation 
assay was primari ly used to investigate the regulatory effects of 
various cytokines on C6 cells. Moreover, the cytokine-induced C6 cell 
proliferation was used as a major parameter to monitor the second 
messenger systems that mediate the actions of cytokines. 
In the first set of experiments, the modulatory effects of various 
cytokines, including TNF-a, IL- la, IL- lp and LIF on C6 glioma cell 
proliferation were examined. Attempts were also made to determine 
whether combinations of these cytokines can act synergistically or 
antagonistically in C6 cell proliferation. In the second set of 
experiments, the involvement of second messenger systems in 
cytokine-induced C6 cell proliferation was studied, w i th particular 
reference to the activation of protein kinase C and tyrosine kinase, 
the roles of cyclic nucleotides and nitric oxide etc. PKC, a common 
second messenger system in many cell types, was first examined 
since its activity is very high in C6 glioma cells. Two PKC activators, 
12-myristate 13-acetate (PMA) and phorbol-12,13-diacetate (PDA), 
were studied for their effects on C6 cell proliferation. Also, three PKC 
inhibitors, staurosporine, calphostin C and Ro31-8220, were tested if 
they could inhibit the proliferation of C6 cells triggered by cytokines 
or PKC activators. In addition, the possible involvement of tyrosine 
kinase, cyclic AMP or GMP, nitric oxide and P-adrenergic receptor in 
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cytokine-induced C6 cell proliferation was examined using specific 
inhibitors, agonists or antagonists. 
In addition, the role of Ca2+ in cytokine-triggered C6 cell 
proliferation was elucidated. The intracellular Ca〗+ level in C6 cells 
was raised by incubating C6 cells wi th calcium ionophore, and 
reduced by addition of calcium channel blockers, such as LaCl3, 
verampil and nifedipine, or the calcium chelator, EGTA. 
It is known that the C6 glioma cell line has bipotential glial 
progenitor properties. During its development, the early passage C6 
cells can be induced to express the astrocytic or oligodendrocytic 
phenotype by different stimuli. By morphological study and 
GFAP/ hematoxylin staining, the influence of cytokines on the 
differentiation the rat C6 glioma cells was also examined. By 
studying the modulatory effects of well-characterized cytokines on 
C6 cell proliferation and differentiation in vitro, i t is hoped that this 
would provide valuable information on the biological role of 
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2.1 Rat C6 Glioma Cell Culture 
2.1.1 Preparation of Culture Media 
2.1.1.1 Complete Dulbecco's Modified Eagle Medium 
Dulbecco's modified Eagle medium (DMEM) wi th high glucose 
and L-glutamine was purchased from Gibco Lab. (Grand Island, NY, 
U.S.A.). The powdered DMEM for 1 liter solution and 3.7 g sodium 
bicarbonate (NaHCO3) were dissolved in 1 liter of double-distilled 
water. The medium was adjusted to p H 7.2 and filtered (filter: 0.2 jum. 
Micro Filtration Systems, Dublin, CA, U.S.A.) immediately under 
suction. Then, horse serum (Gibco) and antibiotics (penicillin, 10,000 
U / m l ; streptomycin, 10,000 ^g/ml ; fungizone, 25 ^g /m l ; Gibco) were 
added, the complete DMEM (CDMEM) obtained contains 10% (v /v ) 
horse serum and 100 U / m l penicillin, 100 ^ g / m l streptomycin and 
0.25 | i g /m l fungizone. This medium was stored at 4。C unti l use. 
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2.1.1.2 Complete Roswell Park Memorial Institute 1640 Medium 
Roswell Park Memorial Institute (RPMI) medium was prepared 
almost the same as DMEM except that 2.0 g sodium bicarbonate 
(NaHCO3) was added. The complete RPMI (CRPMI) medium 
contains 10% (v /v ) fetal bovine serum (FBS, Gibco), 100 U / m l 
penicillin, 100 ^ig/ml streptomycin, and 0.25 ^ig/ml fungizone. 
Because RPMI medium contains N-[2-hydroxyethyl]piperazine-N'-[2-
ethanesulfonic acid] (HEPES) as a buffering system, its p H is more 
stable than DMEM; hence, the CDMEM was used in the maintenance 
of cell culture while the CRPMI medium was used in assays. 
2.1.2 Maintenance of the C6 Cell Line 
Rat C6 glioma cells were obtained from the American Type 
Culture Collection (U.S.A.). They were cultured, under aseptic 
conditions, in CDMEM at 37 °C in a humidified incubator (Shel-Lab, 
Model 2400, Sheldon Manufacturing, Inc.) under an atmosphere of 
50/0 CO2/95 % air. 
The cells were subcultured after 2-3 days in culture, at which 
time they had reached confluence. For the subculture procedure, the 
medium was discarded, and cells washed wi th sterilized phosphate 
buffered saline (PBS, 8.18 g NaCl, 0.2 g KC1, 0.2 g K H 2 P O 4 and 1.44 g 
Na2HPO4 2H2O per liter double-distilled water, p H 7.4). The cells 
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were treated w i th 1 m l of 0.25% trypsin (Gibco) at 37。C for 5 minutes. 
Then 10 m l of CDMEM was added and the cells were dispersed by 
repeated pipetting. After the cells were washed twice w i th DMEM, 
they were adjusted to a cell density of 10^ cel ls/ml and further 
cultured in a 75 cm^ culture flask (Falcon, Becton Dickinson Labware, 
NJ, U.S.A.) containing 20 ml CDMEM. 
For long-term storage, 1 ml of cells (10^ cells) suspended in FBS 
wi th 5% dimethyl sulfoxide (DMSO, Sigma) was stored in l iquid 
nitrogen in plastic ampoules (Nunc., Denmark). When required, 
aliquots were thawed rapidly in CDMEM at 37°C, subcultured and 
cells of passages 18-28 were used in this study. To ensure the puri ty 
of the cell line, cells were checked regularly for contamination under 
a microscope and histochemically wi th antibody against glial 
fibril lary acidic protein (see Section 2.9 for details). 
2.1.3 Cell Preparation for Assays 
As described above, cells of passages 18-28 were trypsinized, 
centrifuged and resuspended in CRPMI medium. For assays using 
96-well microtiter plate (Corning Laboratory Sciences Company, 
U.S.A.), 0.1 m l of 2 . 5x104 cells/ml cell suspension was added to each 
well. For 24-well plate and 6-well plate (Corning, U.S.A.), 0.5 m l cells 
( 3 x 1 0 4 cells/ml) or 1 ml cells (7 .5x104 cells/ml) were seeded in each 
well respectively. 
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2.2 Determination of Cell Proliferation 
2.2.1 Determination of Cell Proliferation by PH]-Thyrrddine 
Incorporation 
Rat C6 glioma cells were treated and plated as described in 
Section 2.1.3. A l l procedures were performed under aseptic 
conditions in a cell culture hood (Biogard hood, the Baker Company, 
Inc.). 
To study the effects of cytokines and/or drugs on C6 cell 
proliferation, cells were incubated in the presence, or absence of 
cytokine(s), w i th or without the addition of drug(s) for various time 
periods as indicated in the text. Then, 0.5 [iCi PH]-thymidine (specific 
activity: 2 Ci /mmol ; Amersham, U.K.) was added to each wel l and 
further incubated for 6 hours to estimate the incorporation of PH]-
thymidine into DNA. At the end of incubation, cells were frozen and 
thawed once and harvested wi th a semi-automatic cell harvester 
(Flow Lab, U.K.). The radioactivity trapped by glass-fiber filters 
(GF/C, Whatman, U.S.A.) was determined in a l iquid scintillation 
counter (Beckman, Model LS 1801, U.S.A.) 
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2.2.2 Measurement of Cell Viability Using Neutral Red Assay 
To test for the viability of the cells fol lowing cytokine and/or 
drug treatment, cells were plated in a 96-well microtiter plate as 
described in section 2.2.1, except that the cell density was adjusted to 
105 cells/ml. After 48 hours of incubation, the medium was removed, 
and the wells were washed wi th 150 )il normal saline (0.9 % NaCl) 
followed by 50 ^1 neutral red solution (0.5% neutral red in normal 
saline). Then the cells were incubated wi th 0.5% neutral red solution 
(100 ^1 per well) at 37。C for 1 hour. After washing six times w i th 
normal saline, 100 jiil of 1% sodium dodecylsulfate (SDS, Sigma) was 
added to each well to solublize the cells and to release the neutral red 
dye. The plate was shaken in a plate shaker (Lab-Line Instruments, 
Inc.) for 2 hours and the optical density (OD) at 540 nm was 
determined wi th a microplate reader (Bio-Rad, Model 3550). 
2.2.3 Data Analysis 
The cytokine or drug induced C6 cell proliferation was 
measured by the increase in the amount of PH]-thymidine 
incorporated and expressed as % stimulation. This was calculated by 
subtracting the counts per minute (CPM) determined in the absence 
of cytokine and/or drug (control) from the CPM determined in the 
presence of cytokine and/or drug (sample), then divided by the 
control CPM which is shown as follows: 
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% Stimulation = 100 X ( C P M s a m p l e - C P M c o n t r d ) / C P M c o n t r o l 
The measurement of cell growth was expressed as % 
stimulation according to the formula below: 
% Stimulation = 1 0 0 X ( O D s a m p l e - 〇 D c 。 n t r 。 l ) / 〇 D con t ro l 
A l l results were expressed as the arithmetic mean 土 standard 
error of quadruplicate determinations. The data shown were 
representative of at least 2-3 similar experiments. The Student's " t " 
test was used to determine the confidence limits in group 
comparison. Normally p< 0.05 was regarded as significantly 
different. 
2.3 Effects of Cytokines and Lipopolysaccharide on C6 
Cell Proliferation 
Recombinant human and mouse tumor necrosis factor-a (TNF-
a, specific activity is 6 x lCF U/mg) were obtained from Boehringer 
Mannheim (Germany), whereas interleukin-la (IL-la, specific 
activity is 1 x 10» U/mg), interleukin-ip (IL-ip, specific activity is 1 x 
108 U/mg), interleukin-6 (IL-6, specific activity is 5 x 10^ U/mg) and 
leukemia inhibitory factor (LIF, specific activity is 1 x 10^ U/mg) 
were obtained from R & D Systems (U.S.A.). Lipopolysaccharide 
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(LPS) was purchased from Sigma (U.S.A.). Cytokines were dissolved 
in RPMI medium containing 2% heat-inactivated (56。C for 30 
minutes) FBS, while LPS was prepared in sterilized PBS. Cytokines 
were stored in aliquots at -20 ^ C, except LPS at -70 °C unt i l use. 
For the time course of cell proliferation triggered by various 
cytokines, cells were cultured in 96-well microtiter plate overnight, 
then the medium was removed and cells were exposed for 15, 30, 60, 
90, 120 or 240 minutes to cytokines, after which cells were washed 
twice w i th CRPMI medium and further incubated unt i l a total period 
of 48 hours. The PH]-thymidine incorporation was determined as 
described in Section 2.2.1. 
2.4 Effects of Protein Kinase C Activators and Inhibitors 
on Cytokine-induced C6 Cell Proliferation 
Two kinds of PKC activators: phorbol 12-myristate 13-acetate 
(PMA, Sigma) and phorbol-12,13-diacetate (PDA, Sigma), were 
dissolved in absolute ethanol at 1.62 m M and 2.23 m M respectively, 
and stored at -20 °C unti l use. On the other hand, three kinds of PKC 
inhibitors: staurosporine (ST, Sigma), calphostin C (Cal C, Sigma) and 
3-{l-[3-(Amidinothio)propyl]-3-indolyl)-4-(l-methyl-3-indolyl)-lH-
pyrrole-2,5-dione methanesulfonate (Ro31-8220, Roche Producs Ltd., 
U.K.), were dissolved in absolute ethanol, RPMI medium and DMSO, 
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respectively (Sigma) at concentrations of 100 ^M, lO^M and 100 ^ M 
before use. 
The effects of PMA and PDA on C6 cell proliferation and the 
effects of ST, Cal C and Ro31-8220 on TNF-a (100 U / m l ) or LIF (1 
ng / ml)-induced C6 cell proliferation were assayed as described in 
Section 2.2.1. 
2.5 Effects of cAMP or cGMP on Cytokine-induced C6 
Cell Proliferation 
N^-2'-0-dibutyryl cyclic adenosine-3',5'-monophosphate 
(dbcAMP, Sigma) and N6-2'-0-dibutyryl cyclic guanosine-3'.5'-
monophosphate (dbcGMP, Sigma) were dissolved in RPMI medium 
at 10 m M and stored in -20。C unti l use. The effects of dbcAMP or 
dbcGMP alone, or in combination wi th TNF-a or LPS on C6 cell 
proliferation were studied as described in Section 2.2.1. 
2.6 Effects of Tyrosine Kinase Inhibitors on Cytokine-
induced C6 Cell Proliferation 
Two kinds of tyrosine kinase (TK) inhibitors: tyrphostin (TYR, 
Sigma) and herbimycin A (Her A, Sigma), were dissolved in RPMI 
medium and stored at -20 ^C before use. C6 glioma cells were 
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exposed to different doses of TYR or Her A in the presence or 
absence of TNF-a (100 U/mI) , or LIF (1 ng/ml ) for 48 hours, and cell 
proliferation assay was studied as described in Section 2.2.1. 
2.7 Effects of Calcium Ion on Cytokine-induced C6 Cell 
Proliferation 
In these experiments, C6 cells were exposed to ethylene glycol-
bis (p-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA, Sigma), a 
calcium ion chelator; lanthanum chloride (LaCl3) (Sigma), verampil 
(Sigma) or nifedipine (Sigma), all are calcium ion channel blockers; or 
A23187 (Sigma), a calcium ionophore; in the presence or absence of 
various concentrations of TNF-a or LIF for 48 hours. Then, PH]-
thymidine incorporation in C6 cells was examined as described in 
Section 2.2.1. Because some calcium drugs are light sensitive, 
experiments were carried out in the dark and the culture plates were 
wrapped wi th aluminum foil. 
2.8 Effects of Nitric Oxide on Cytokine-induced C6 Cell 
Proliferation 
2.8.1 Effects of Sodium Nitroprusside and Nitric Oxide Synthase 
Inhibitors on Cytokine-induced C6 Cell Proliferation 
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Sodium nitroprusside (SNP, Sigma), an exogenous nitric oxide 
donor, was used to investigate the effect of nitric oxide on C6 cell 
proliferation. SNP was freshly prepared in PBS (20 mM) and diluted 
in CRPMI medium before use. 
On the other hand, NG-methyl-L-arginine (NMA, 10 m M in 
RPMI medium, Sigma) and N^-nitro-L-arginine methyl ester (NAME, 
20 m M in RPMI medium, Sigma), both being nitric oxide synthase 
inhibitors, were added to C6 glioma cell cultures in the presence or 
absence of TNF-a (100 U /m l ) or LIF (1 ng/ml) . The method for PH]-
thymidine incorporation was the same as described in Section 2.2.1. 
2.8.2 Nitric Oxide Production Assay 
Nitric oxide (NO) formation was detected by nitrite 
accumulation in the culture supernatant using Griess reaction (Green 
et aL, 1982). In aqueous solution, NO reacts rapidly w i th O2 and 
accumulates in the culture medium as nitrite and nitrate ions. Nitrite 
forms a chromophore wi th the Griess reagent and thus its 
concentration can be determined by a colorimetric assay. C6 glioma 
cells were incubated at 37^C with different cytokines in a 96-well 
microtiter plate (Section 2.2.1). After 72 hours, 50 ^1 cell free 
supernatant was transferred to another 96-well microtiter plate. Then, 
an equal volume (50 jul) of freshly prepared Griess reagent was added 
to the well, and the plate was shaken at room temperature for 15 
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minutes. Griess reagent consists of one part of 0.1% 
napthylethylenediamine dihydrochloride in distilled water and one 
part of 1% sulfanilamide in 5% concentrated H3PO4. The absorbance 
was read at a wavelength of 540 nm by a microplate reader (Bio-Rad, 
Model 3550). The nitrite concentration can be quantified using 
sodium nitrite (0 - 50 |iM) as a standard. 
2.9 Effects of p-Adrenergic Receptor Agonist and 
Antagonist on C6 Cell Proliferation 
Isoproterenol, a p-adrenergic receptor agonist, and propranolol, 
an antagonist of the p-adrenergic receptor, were purchased f rom 
Sigma Chem. Co. They were dissolved in double-distilled water at 
250 m M and 10 m M respectively and stored at -20^C unt i l use. C6 
glioma cells were cultured for 48 hours in control medium, 1 juM of 
isoproterenol, or TNF-a (10 U / m l or 100 U/ml ) , plus various 
concentrations of propranolol (0 - 25 juM), and the PH]-thymidine 
incorporation was determined as described in Section 2.4. 
2.10 Morphological Studies on Cytokine-Treated C6 
Glioma Cells 
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A l l photographs were taken under the Axiophot microscope 
(Zeiss, 7082 Oberkocken, Germany). The cells were prepared and 
stained as described below. 
2.10.1 Wright-Giesma Staining 
o o 
C6 glioma cells were plated on 15 m m cover slips placed in 6-
wel l plates and incubated wi th or without TNF-a (100 U /mI ) or LIF 
(1 ng/ml ) , according to the protocols in Section 2.1.3. After 24, 48 or 
72 hours of incubation, the cells were washed wi th PBS, stained w i th 
modified Wright-Giemsa staining solution (Sigma) for 30 seconds, 
followed by destaining. The air-dried cover slips were mounted wi th 
Canada Balsam mounting solution and the morphology examined 
under a l ight microscope. 
2.10.2 Glial Fibrillary Acidic Protein Staining 
C6 glioma cells were plated on 12 m m cover slips placed in 24-
wel l plates and incubated wi th different doses of TNF-a or LIF. After 
48 hours of incubation, cultures were fixed wi th 4% 
paraformadehyde in 0.1 M PBS for 15-30 minutes at room 
temperature. Then, the cells were exposed to primary antibody 
(rabbit IgG anti-glial fibrillary acidic protein (anti-GFAP, Sigma)) for 
2 hours at room temperature, followed by secondary antibody (goat 
anti-rabbit IgG, Sigma) for 1 hour at room temperature. After the 
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immuno-reactions, the cells were treated wi th Vectastain Elite ABC 
Ki t (Vector Laboratories) for 1 hour at room temperature, and then 
incubated w i th 3,3'-diaminobenzidine solution (10 mg/10 m l 0.05M 
Tris, p H 7.5) containing 0.01 % H2O2 for about 2-5 minutes to develop 
the color. Cells were stained wi th hematoxylin (see Section 2.10.3) 
and examined microscopically, and the percentage of GFAP positive 
cells were scored by counting at least 200 cells. 
2.10.3 Hematoxylin Staining 
C6 glioma cells plated on 12 m m cover slips were treated w i th 
cytokines, and stained wi th anti-GFAP antibody according to the 
methods described above (Section 2.9.2). Then, the cells were stained 
w i th Mayer's hematoxylin solution for 1-5 minutes, and washed in 
water. Excess stain was removed selectively by immersing the cover 
slips in acid alcohol (1% HC1 in 70% alcohol) followed by bluing in 
Scott's tap water (alkaline ammonium water). After being washed in 
water, the stained cells were dehydrated stepwise in 70%, 80% and 
95% alcohol quickly, and finally in 100% alcohol three times for five 
minutes each time. 
Mayer's hematoxylin solution consists of the fol lowing 
ingredients: hematoxylin 5 g, ammonium alum 50 g, sodium iodate 
0.3 g, distilled water 700 ml, glycerol 300 mI and glacial acetic acid 20 
mL For the preparation of the Mayer's hematoxylin solution, 
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ammonium alum was poured into distilled water, and the solution 
was boiled. Then, hematoxylin was added and the ammonium water 
was kept boil ing for further 2 minutes. When sodium iodate was 
added, the solution was stirred and cooled down. As the last step, 
glycerol and glacial acetic acid were dissolved in the solution. Finally, 
the solution was filtered before use. 
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Chapter 3 RESULTS 
3.1 Effects of Cytokines on C6 Cell Proliferation 
Since cytokines play an important role in the communication 
between cells of the immune and nervous systems (Benveniste, 
1992a; Mart in & Tracey, 1992), i t is of considerable interest to study 
their effects on astrocytes, the most abundant cell type in the CNS. 
Astrocytes are reported to express a number of different cytokine 
receptors which are known to be important in regulating the 
proliferation and differentiation of astrocytes (Benveniste, 1992a). 
Like astrocytes, C6 glioma (astrocytoma) cells also respond to a large 
number of cytokines, including TNF-a, IFN-y, IL-4 and IL-6 (Brodie & 
Goldreich, 1994; Munoz-Fernandez & Fresno, 1993; Simmons & 
Murphy, 1992; 1993), thus they represent a good model system for 
studying the conditions and factors which regulate the development 
and differentiation of glial cells and the signalling pathways that 
might be involved in these processes (Mangoura et al., 1989). In this 
thesis project, the effects of various cytokines in triggering DNA 
synthesis in C6 glioma cells were examined. In the first set of 
experiments, C6 glioma cells were treated wi th different cytokines, 
such as TNF-a, IL- la, IL-ip, IL-6 and LIF, for various time periods, 
and the PH]-thymidine incorporation was measured according to the 
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methods described in Section 2.2.1. Moreover, since LPS is known to 
stimulate the production of cytokines (Lee et al" 1993b), the effect of 
LPS on C6 cell proliferation was also investigated. 
3.1.1 Effects of Cytokines on C6 Cell Proliferation 
In this study, C6 glioma cells were cultured w i th different 
cytokines at various concentrations, including TNF-a, IL- la , IL- lp, 
IL-6 and LIF, and the PH]-thymidine incorporation was measured. 
Fig. 3.1 showed the effects of recombinant mouse and human TNF-a 
on C6 cell proliferation. The proliferation of C6 cells was increased by 
mouse, or human, TNF-a in a dose-dependent manner and in case of 
mouse TNF-a, the proliferation also increased in a time-dependent 
manner. Moreover, the proliferative effect of mouse TNF-a was 
found to be more potent than that of the human one. With the mouse 
TNF-a, optimal stimulation (an increase of 62 %, in pH]-thymidine 
incorporation) was obtained with 100 U / m l TNF-a after 48 hours of 
incubation and the stimulatory effect declined at a higher 
concentration of TNF-a (500 U/ml) . Because of these observations, 
mouse but not human TNF-a was used in all subsequent studies, and 
48 hours incubation was chosen in the following experiments. 
As it has been reported that TNF exerted its proliferative effect 
via the biosynthesis and/or secretion of other cytokines (Frei et aL, 
1989), thus the effects of other cytokines were studied. Fig. 3.2 
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Fig. 3.1 The effects of mouse and human TNF-a on C6 cell 
proliferation. PH]-thymidine incorporation was determined 
according to the methods in Section 2.3 and expressed as percentage 
of stimulation as described in Section 2.2.3. Each point represents the 
mean 士 standard error of four replicate wells. The X-axis was 
represented in a logarithmic scale. 
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Fig. 3.2 The effects of LIF and IL-6 on C6 cell proliferation. C6 cells 
were cultured wi th various concentrations of LIF or IL-6 for 48 hours, 
and PH]-thymidine incorporation was determined as described in 
Section 2.3. Results were expressed as percentage of stimulation and 
each point represents the mean 土 standard error of quadruplicate 
wells. The X-axis was represented in a logarithmic scale. 
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showed the results of IL-6 and LIF on C6 cell proliferation. IL-6 at the 
range of 0.01-10 n g / m I had no significant effect on C6 cell 
proliferation. On the other hand, LIF was very effective at 
concentrations f rom 0.4 ng /m I to 5 ng/ml . Maximum stimulation 
(51% increase in PH]-thymidine incorporation) was obtained w i th 1 
n g / m I of LIF. A t concentrations lower than 0.1 n g / m l of LIF, no 
stimulation was observed, while slight inhibition was seen at 10 
ng /ml . The latter may be due to the cytotoxic effect of LIF at higher 
doses. 
In addition to TNF-a and LIF, IL - la and IL- lp also showed dose-
dependent stimulation on C6 cell proliferation, and maximum 
stimulation of 65 % and 67 % were observed wi th 1 n g / m l of I L - l a 
and 100 p g / m I of IL- lp, respectively (Fig. 3.3). These two interleukins 
appeared to be more potent than LIF as stimulation was observed 
wi th p g / m l of either IL-1, while ng /m l of LIF was required to attain 
similar stimulation. Additionally, IL- ip was found to be more 
effective than IL- la, especially at lower concentrations. 
3.1.2 The Time Course of Cytokine-induced C6 Cell Proliferation 
Preliminary studies showed that 100 U / m l TNF-a or 1 n g / m l LIF 
could induce maximal proliferation of the C6 glioma cells, therefore 
these concentrations were used to investigate the time course for the 
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Fig. 3.3 The effects of I L - l a and IL- ip on C6 cell proliferation. C6 
cells were cultured wi th various concentrations of I L - l a or IL - lp for 
48 hours, and PH]-thymidine incorporation was determined as 
described in Section 2.3. Results were expressed as percentage of 
stimulation and each point represents the mean 土 standard error of 
quadruplicate wells. Significant difference between the 
corresponding points of IL - la and IL- lp (P<0.05) was indicated by an 
asterisk. The X-axis was represented in a logarithmic scale. 
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proliferative effect of these two cytokines. The experimental 
procedure used was as described in Section 2.3. 
Fig. 3.4 showed the results of C6 cell proliferation after exposing 
the cells to 100 U / m l TNF-a or 1 n g / m l LIF for different durations. 
The proliferative effect induced by these two cytokines did not 
require the continuous presence of these cytokines in culture. 
Significant stimulation was observed after 60 minutes exposure to 
100 U / m l of TNF-a, and higher stimulation was observed at longer 
incubation periods. On the other hand, treatment wi th 1 n g / m l of LIF 
for 15 minutes caused significant stimulation, which increased only 
slightly at longer incubation periods. Because of the rapid 
proliferative action of this cytokine, LIF was also included in the 
second messenger study (Section 3.3) in order to determine if TNF-a 
and LIF triggered different signalling pathways in C6 cells. 
3.1.3 Effects of Lipopolysaccharide on C6 Cell Proliferation 
LPS has been shown to induce cytokine production in human 
primary cultured astrocytes (Lee et al 1993b), i t was therefore of 
interest to examine if LPS could also affect cell proliferation in C6 
cells. Fig. 3.5 showed the effect of various doses of LPS on C6 cell 
proliferation. The stimulatory effect of LPS was both dose-dependent 
and time-dependent, and maximum stimulation (50 % increase in 
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Fig. 3.4 The time course of C6 cell proliferation induced by TNF-a or 
LIF. The C6 glioma cells were seeded overnight and then incubated 
w i th TNF-a or LIF for different durations as shown, and pH]-
thymidine incorporation was determined as described in Section 2.3. 
Results were expressed as percentage of stimulation and each point 
represents the mean 土 standard error of quadruplicate wells. The X-
axis was represented in a logarithmic scale. 
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Fig. 3.5 Effects of exposure time and doses of LPS on C6 cell 
proliferation. PH]-thymidine incorporation was carried out as 
described in Fig 3.1 and results were expressed as the percentage of 
stimulation as described in the Section 2.3. The results were obtained 
in the presence of different doses of LPS for 1, 2 and 3 days. Values 
shown are mean 土 standard error of quadruplicate wells. The X-axis 
was represented in a logarithmic scale. 
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PH]-thymidine incorporation) was obtained wi th 100 n g / m l LPS 
after 48 hours of incubation. 
3.1.4 Effects of Cytokines on the Growth of C6 Cells 
In order to examine if cell growth was affected by different 
cytokines, the C6 glioma cells were cultured in the presence of 
different doses of cytokines, then the cell growth was monitored w i th 
the uptake of the vital dye neutral red as described in Section 2.2.2. 
After 48 hours of incubation, there was no significant change in cell 
number compared wi th the control (data not shown). However, after 
72 hours of treatment wi th cytokines-TNF-a, LIF, IL - la or IL- lp, the 
cell number was markedly increased (Fig. 3.6). Among the two forms 
of interleukin 1 studied, IL- lp appeared to be more effective than IL-
l a in stimulating C6 cell growth (Fig. 3.6B). 
3.2 Morphology and GFAP Expression in Cytokine-
treated C6 Glioma cells 
3.2.1 Effects of Cytokines on the Morphology of C6 cells 
As discussed in the introduction, early passages of C6 glioma 
cells exhibit progenitor properties and can differentiate into either 
oligodendrocytic or astrocytic phenotype (Brodie & Vernadakis, 1991; 
Parker et al., 1980). Moreover, cell morphology has been shown to be 
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Fig. 3.6 biduction of C6 ceU growth by TNF-a (A), LIF and IL-1 a or p (B). 
C6 ceUs were cultured for 3 days in the presence or absence of various 
concentrations of cytokines. The ceU growth was estimated with neutral 
red staining as described in Section 2.2.2. Results were expressed as 
percentage of stimulation and each point represents the mean 士 standard 
error of quadruplicate weUs. The X-axis was represented in a logarithmic 
scale. 
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a useful criterion for monitoring cell differentiation (Brodie & 
Vernadakis, 1991; Vernadakis et al, 1991). Therefore, i t is of interest 
to know whether treatment wi th cytokines can alter the 
morphological appearance of C6 cells. In this study, C6 glioma cells 
were exposed to cytokines, including 100 U / m l TNF-a and 1 n g / m l 
LIF 3 days before they were stained wi th the Wright-Giemsa stain. It 
was observed that these cytokines did not induce significant 
morphological changes except that the cells were smaller (Fig. 3.7) 
Although no significant changes in morphology were observed, there 
was a clear increase in the cell number in each case. This observation 
is in agreement wi th the results that these cytokines significantly 
increased the PH]-thymidine incorporation in C6 cells. 
3.2.2 The Effects of Cytokines on GFAP Expression in C6 Glioma Cells 
Since early passages of C6 glioma cells can be stimulated to 
differentiate into oligodendrocytic or astrocytic phenotype, the 
expression of GFAP was examined wi th anti-GFAP antibodies. Figure 
3.8 showed C6 cells incubated wi th 100 U / m l of TNF-a or 1 n g / m l 
LIF for 48 hours, followed by exposure to anti-GFAP antibodies. No 
obvious changes in cell morphology could be observed except that 
the size of the cytokine-treated cells was smaller. Interestingly, i t was 
found that the number of GFAP-negative cells in the LIF-treated cells 
was slightly higher than that of the untreated control cells, whereas 
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Fig. 3.7 Effect of TNF>a and UF treatment on the morphology of C6 cells. C6 
cells were cultured on a 15 mm cover slip in the presence of 100 U/ml TNF-a 
(B) or 1 ng/ml UF (C) or in medium (A) for 3 days, then stained with Wright-
Giesma stain as described in Section 2.10.1. The bar represents 50 ^m. 
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Fig. 3.8 Effect of TNF-a and UF treatment on the morphology of C6 ceUs. C6 
ceUs were cultured on a 12 mm cover sHp in the presence of 100 U/ml TNF^ 
(B) or 1 ng/ml UF (C) or in medium (A) for 2 days, then stained with 
GFAP/hematoxylin stain as described in Section 2.10.2 and 2.10.3. The bar 
represents 50 ^m. 
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no significant difference was observed between the control and the 
TNF-a-treated cells (Fig. 3.9). 
3.3 The Signalling Pathway of Cytokine-induced C6 Cell 
Proliferation 
Experiments described in Section 3.1 showed that several 
cytokines could induce C6 glioma cell proliferation; however, the 
underlying mechanism remains unclear and very little is known 
about the signal-transduction pathways mediating the action of 
various cytokines. Since TNF-a and interleukin-l have been reported 
to stimulate various second messengers in primary glial cell cultures 
(Norris et al, 1994), the possible involvement of various signalling 
pathways in cytokine-induced proliferation in C6 cells was studied. 
The second messenger systems examined include protein kinase C 
(PKC), tyrosine kinase (TK), calcium ions, cyclic nucleotides, as well 
as the nitric oxide. As the p-adrenergic mechanism has been shown to 
stimulate proliferation in primary astrocyte cultures (Mantyh et al” 
1995), therefore, the effects of isoproterenol, a p-adrenergic agonist, 
on cytokine-induced proliferation in C6 cells were investigated to see 
if a relationship exists between p-adrenergic mechanism and the 
inflammatory cytokines. 
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Fig- 3.9 Effect of cytokine treatment on GFAP expression in C6 cells. 
Cells were incubated wi th TNF-a (100 U/ml) , or LIF (1 ng/ml ) for 2 
days, then exposed to GFAP antibodies and followed by hematoxylin 
staining as described in Section 2.10.2 and 2.10.3, and the percentages 
of the GFAP positive cells were counted. Values shown are means 土 
standard error of three determinations. *P<0.05, significantly 
different from control by using the Student's t-test. 
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3.3.1 The Involvement of Protein Kinase C in Cytokine-induced C6 
Cell Proliferation 
Since certain cytokines have been shown to induce 
phosphatidycholine hydrolysis (Cataldi et al, 1990) and activate 
certain PKC isozymes (Pfeffer et al., 1990), i t is of interest to see if 
PKC is involved in mediating the proliferative effect of cytokines in 
C6 cells. In the present study, phorbol 12-myristate 13-acetate (PMA) 
and phorbol-12,13 diacetate (PDA), which are potent PKC activators 
(Hug & Sarre, 1993), were used to investigate whether the 
proliferative effect of cytokines is mediated through activation of 
PKC In the range of 8.11 p M to about 1.62 n M PMA and 22.2 p M to 
about 2.23 n M PDA, either PKA activator was able to increase DNA 
synthesis in C6 cells. The maximum stimulation was observed w i th 
162 p M PMA and 223 p M PDA respectively (Fig. 3.10). 
To test if PKC mediated the proliferative effect of TNF-a and LIF, 
the effect of three PKC inhibitors on cytokine-induced C6 cell 
proliferation was investigated. The three PKC inhibitors examined 
were staurosporine, calphostin C and Ro31-8220, and all of them 
have been shown to be potent PKC inhibitors (Davis et al., 1992; H u 
& Fan, 1995; Tamaoki et al, 1986). Incubation of the cells in any one of 
these three PKC inhibitors caused a slight (maximum 10 %) 
stimulation in C6 cells (Figs. 3.11-3.13), except at higher 
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Fig- 3. 10 Effects of PKC activators on C6 cell proliferation. C6 
glioma cells were treated wi th various concentrations of PMA or 
PDA for 48 hours, and proliferation was assayed as described before 
(Section 2.4). Values shown are mean 士 standard error of 
quadruplicate wells. The X-axis was represented in a logarithmic 
scale. ECso is the concentration of drug which causes 50 % of 
maximum stimulation. Estimated EC50： PMA « 12.3 pM, PDA « 16 7 
pM. 
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Fig. 3.11 Effects of various concentrations of staurosporine on TNF- i 
a or LIF-induced proliferation of C6 cells. Cells were cultured for 48 ‘ 
hours w i th or without TNF-a (100 U /m l ) or LIF (1 ng /m l ) in the 
presence of indicated concentrations of staurosporine. D N A 
synthesis was estimated as described before (Section 2.4). Values 
shown are mean 士 standard error of quadruplicate wells. IC50 is the 
concentration of the drug which inhibits 50 % of maximum 
stimulation. Estimated IC50 values: TNF-a « 0.3 nM, LIF « 0.34 nM. 
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Fig. 3.12 Effects of various concentrations of calphostin C on TNF-a 
or LIF-induced proliferation in C6 cells. Cells were cultured for 48 
hours wi th or without TNF-a (100 U/ml ) or LIF (1 ng/ml ) in the 
presence of indicated concentrations of calphostin C. DNA synthesis 
was estimated as described before (Section 2.4). Values shown are 
mean 土 standard error of quadruplicate wells. The X-axis was 
represented in a logarithmic scale. Estimated IC50: TNF-a « 4.3 nM, 
LIF « 1 nM. 
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Fig. 3.13 Effects of various concentrations of Ro31-8220 on TNF-a or 
LIF-induced proliferation of C6 cells. C6 cells were cultured for 48 
hours w i th or without TNF-a (100 U/ml ) or LIF (1 ng /ml ) in the 
presence of indicated concentrations of Ro31-8220. DNA synthesis 
was estimated as described before (Section 2.4). Values shown are 
mean 土 standard error of quadruplicate wells. The X-axis was 
represented in a logarithmic scale. Estimated IC50: TNF-a « 1 5 nM, 
LIF «10 nM. 
75 
Chapter 3 Results 
concentrations of staurosporine (0.5 nM) or calphostin C (100 nM) 
where a slight inhibitory effect was observed (Fig. 3.11 and 3.12). 
Staurosporine at a low concentration (0.125 nM) inhibited the 
proliferation induced by the optimal dose of TNF-a (100 U /m l ) , or 
LIF (1 ng/mI) significantly, and complete inhibit ion of the 
proliferative action induced by either TNF-a or LIF was observed 
w i th 0.5 n M of this inhibitor (Fig. 3.11). The IC50 values for TNF-a 
and LIF were estimated to be 〜0.3 n M and 〜0.34 n M of staurosporine, 
respectively. 
Calphostin C, which is a potent PKC inhibitor, reduced the 
proliferation induced by TNF-a or LIF in a concentration-dependent 
manner (Fig. 3.12); and complete or almost complete inhibit ion was 
observed w i th 50 n M of calphostin C. The IC50 values for TNF-a and 
LIF were estimated to be 〜4.3 nM and 〜1 nM, respectively. 
To ensure that the proliferative effect of TNF-a and LIF was 
mediated through PKC, the effect of Ro31-8220 was tested. Similar to 
calphostin C and staurosporine, Ro31-8220 also reduced the 
proliferative effect of TNF-a and LIF in a concentration-dependent 
manner (Fig. 3.13) The IC50 values for TNF-a and LIF were estimated 
to be 〜15 n M and 〜10 nM, respectively. 
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Comparing the inhibitory effects of the three PKC inhibitors 
examined, staurosporine, calphostin C and Ro31-8220 (Fig. 3.11 -
3.13), i t was clear that the inhibitory effect of these three inhibitors 
was in the order of staurosporine » calphostin C > Ro31-8220. 
Results described above showed that the PKC activators 
stimulated proliferation in C6 cells (Fig. 3.10), and the proliferative 
effect of TNF-a and LIF was blocked by PKC inhibitors (Figs. 3.11-
3.13). In order to demonstrate that PKC was indeed involved in the 
proliferation of C6 cells, cells were treated wi th optimal dose of PMA 
or PDA in the presence of different concentrations of one of the three 
PKC inhibitors for 48 hours before PH]-thymidine incorporation was 
measured. Data showed that DNA synthesis in C6 cells induced by 
either PMA or PDA was significantly inhibited by staurosporine (Fig. 
3.14), calphostin C (Fig. 3.15) or Ro31-8220 (Fig. 3.16) in a dose-
dependent manner. Moreover, the effect of PMA appeared to be 
more sensitive to staurosporine and Ro31-8220 (Figs. 3.14 and 3.16), 
while that of PDA was more sensitive to the action of calphostin C 
(Fig. 3.15). Like the inhibitory effects of these PKC inhibitors on 
cytokine-induced proliferation, staurosporine was the most potent 
inhibitor of PKC activator-induced proliferation in C6 cells, and 
complete inhibition was observed with 0.25 nM of staurosporine (Fig. 
3.14). Whatever on cytokine- or PKC activator-induced proliferation, 
the effect order of these three inhibitors was parallel to that of their 
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Fig. 3.14 Effects of various concentrations of staurosporine on PMA-
or PDA-induced C6 cell proliferation. C6 cells were cultured for 48 
hours w i th various concentrations of staurosporine, in the presence 
or absence of 1 n g / m l PMA or PDA. DNA synthesis was estimated as 
described before (Section 2.4). Values shown are mean 土 standard 
error of quadruplicate wells. Estimated IC50： PMA « 0.067 nM, PDA « 
0.09 nM. 
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Fig. 3.15 Effects of various concentrations of calphostin C on PMA-
or PDA-induced C6 cell proliferation in C6 cells. Cells were cultured 
for 48 hours w i th various concentrations of calphostin C, in the 
presence or absence of 1 n g / m l PMA or PDA. D N A synthesis was 
estimated as described before (Section 2.4). Values shown are mean 士 
standard error of quadruplicate wells. The X-axis was represented in 
a logarithmic scale. Estimated IC50: PMA « 9 nM, PDA « 0.3 nM. 
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Fig. 3.16 Effects of various concentrations of Ro31-8220 on PMA- or 
PDA-induced C6 cell proliferation in C6 cells. Cells were cultured for 
48 hours w i th various concentrations of Ro31-8220, in the presence or 
absence of 1 n g / m l PMA or PDA. DNA synthesis was estimated as 
described before (Section 2.4). Values shown are mean 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. Estimated IC50： PMA « 1.5 nM, PDA « 7 nM. 
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inhibi t ion on PKC activity (Couldwell et al； 1994; Davis et al., 1992; 
Keller and Niggli, 1993; Kobayashi et al, 1989). 
3.3.2 The Involvement of Tyrosine Kinase in the Cytokine-induced 
C6 Cell Proliferation 
Tyrosine kinase, a common second messenger, was reported to be 
involved in both cytokine and LPS-induced nitric oxide synthase 
expression in C6 cells (Feinstein et al, 1994a). It is of interest to 
examine whether tyrosine kinase activity also plays a role in 
( 
cytokine-induced C6 cell proliferation. Therefore, the effects of two : 
！ 
selective tyrosine kinase inhibitors, herbimycin A and tyrphostin, J 
were investigated in this study. The latter has been reported to be { 
highly specific for the enzyme tyrosine kinase (Bianchi et al, 1995; I 
Feinstein et al, 1994a). Figures 3.17 and 3.18 showed the inhibitory • 
] 
effects of herbimycin A and tyrphostin on TNF-a- and LIF-induced \ 
C6 cell proliferation. Neither inhibitor alone had significant effect on • 
the incorporation of PH]-thymidine, while herbimycin A, at 25 nM, 
and tyrphostin, at around 1 ^M, completely blocked the stimulation 
induced by these two cytokines (Figs. 3.17 and 3.18). This observation 
also suggested that herbimycin A was more potent than tyrphostin, 
as the latter required jiiM concentrations in order to block the 
cytokine-induced proliferation completely. This result was in 
agreement wi th that herbimycin A blocks tyrosine kinase more 
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Fig. 3.17 Effects of various concentrations of herbimycin A on TNF-a 
or LIF-induced proliferation. C6 cells were cultured for 48 hours w i th 
or wi thout TNF-a (100 U /m l ) or LIF (1 ng /ml ) in the presence of 
indicated concentrations of herbimycin A. D N A synthesis was 
estimated as described before (Section 2.4). Values shown are mean 士 
standard error of quadruplicate wells. Estimated IC50: TNF-a » 8.2 
nM, LIF » 5.8 nM. 
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Fig. 3.18 Effects of various concentrations of tyrphostin on TNF-a or 
LIF-induced proliferation. C6 cells were cultured for 48 hours w i th or 
wi thout 100 U / m l TNF-a or 1 n g / m l LIF in the presence of indicated 
concentrations of tyrphostin. DNA synthesis was estimated as 
described before (Section 2.4). Values shown are mean 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. Estimated IC50: TNF-a « 0.14 ^M, LIF « 0.12 /iM. 
83 
Chapter 3 Results 
effectively than tyrphostin (Migita et al； 1994; Gazit et al., 1989). In 
the presence of 25 n M of herbimycin A or 5 ^iM of tyrphostin, almost 
no proliferative effect could be observed (Figs. 3.17 and 3.18). 
Another point to be noted was that the action of LIF appeared to be 
slightly more sensitive to these two tyrosine kinase inhibitors which 
wou ld indicate that the LIF-induced proliferation is mediated, at least 
in part, via tyrosine kinase. 
In order to investigate whether there is any relationship between 
tyrosine kinase and protein kinase C activity on the proliferation of 
C6 cells, the cells were treated wi th a PKC activator in combination 
w i th a tyrosine kinase inhibitor for 48 hours, and cell proliferation 
was measured by the method as described in Section 2.6. From 
Figures 3.19 and 3.20, the stimulatory effect of PMA and PDA was 
blocked by either herbimycin A or tyrphostin. Moreover, herbimycin 
A was found to be more effective than tyrphostin (Compare Figs. 3.19 , 
and 3.20), which was cooperated wi th their inhibitory effects on ‘ 
tyrosine kinase activity (Gazit et al； 1989; Migita et al., 1994). The 
stimulatory action of PDA was more sensitive to these two tyrosine 
kinase inhibitors. Like before (Figs. 3.17 and 3.18), neither herbimycin 
A nor tyrphostin alone showed any significant proliferative effect on 
C6 glioma cells. 
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Fig. 3.19 Effects of various concentrations of herbimycin A on PMA-
or PDA-induced C6 cell proliferation. C6 cells were cultured for 48 
hours w i th various concentrations of herbimycin A, in the presence 
or absence of 1 n g / m l PMA or PDA. DNA synthesis was estimated as 
described before (Section 2.4). Values shown are mean 土 standard 
error of quadruplicate wells. Estimated IC50: PMA « 1 5 nM, PDA « 7 
nM. 
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Fig. 3.20 Effects of various concentrations of tyrphostin on PMA- or 
PDA-induced C6 cell proliferation. C6 cells were cultured for 48 
hours w i th various concentrations of tyrphostin, in the presence or 
absence of 1 n g / m l PMA or PDA. DNA synthesis was estimated as 
described before (Section 2.4). Values shown are mean 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. Estimated ICso： PMA « 36 nM, PDA « 26 nM. 
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3.3.3 The Involvement of Calcium Ions in Cytokine-induced C6 Cell 
Proliferation 
As Ca2+ has been shown to mediate the action of a number of 
neurotransmitters and biologically active peptides (Frazer et aL, 1990; 
Meyer & Mil ler, 1990), the actions of A23187, a calcium ionophore, 
and three different calcium channel blockers, namely LaCl3, verampil 
and nifedipine on cytokine-induced proliferation were tested. 
Figure 3.21 showed the effect of A23187 on cytokine-induced C6 
cell proliferation. A23187 alone was able to increase the proliferation 
of C6 cells, and maximum stimulation was observed w i th 20.7 nM. 
This stimulation was further enhanced by TNF-a, IL- la , IL- ip and 
LIF. Among the cytokines studied, maximum stimulation (72 % 丨 
increase in PH]-thymidine incorporation) was observed w i th 10 
U / m l of TNF-a plus 20.7 nM A23187. In the presence of 83 n M of 
A23187, w i th or without cytokine, the proliferative effect decreased, . 
and this may be due to the cytotoxic effect of this calcium ionophore 
at higher concentrations. 
Since the increase in intracellular calcium ion concentration by 
A23187 stimulated proliferation in C6 cell, the effects of some Ca2+ 
channel blockers were then examined. The three Ca^+ channel 
bl0ckers--LaCl3, verampil and nifedipine, themselves did not affect 
PH]-thymidine incorporation significantly (Figs. 3.22-3.24); however, 
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Fig. 3.21 Effects of A23187 and cytokine on C6 cell proliferation. C6 
cells were cultured for 48 hours in control medium or in the presence 
of a cytokine plus various concentrations of A23187. DNA synthesis 
was estimated as described before (Section 2.4). Values shown are 
means 士 standard error of quadruplicate wells. 
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Fig. 3.22 Effect of LaCl3 on cytokine-induced proliferation in C6 
cells. Cells were cultured for 48 hours wi th or without TNF-a (100 
U / m l ) or LIF (1 ng /ml ) and in the presence of various concentrations 
of LaCl3. PH]-thymidine incorporation was estimated as described 
before (Section 2.4). Values shown are means 土 standard error of 
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Fig. 3.23 Effect of verampil on cytokine-induced proliferation in C6 
cells. Cells were cultured for 48 hours wi th or without TNF-a (100 
U / m l ) or LIF (1 ng /ml ) and in the presence of various concentrations 
of verampil. PH]-thymidine incorporation was estimated as 
described before (Section 2.4). Values shown are means 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. Estimated ICso： TNF-a « 1.25 ^M, LIF « 5.25 jitM. 
90 
Chapter 3 Results 
, 
~ ^ ^ Nifedipine only 
60_r " • “ +100 U/ml TNF-a 
! K " • “ + 1 ng/nd LIF 
50 — ^ x ^ ^ 
^ 4 0 : ^ X ^ _ _ j 
t 3 o ' ^ ^ r X 
i : - ^ ^ \ \ 
^ o|~^—^^^""rV^ 
-10 - \ 
-20 - ^ 
1 1 _ I I I I 1 1 1 I I _ _ ‘ I ' ‘ _ I I _ I * 1 I 1 1 1 I i i I I I 1 1 1 I I I 
0 10 10^  10^  10^  
Nifedipine concentration (nM) 
Fig. 3.24 Effect of nifedipine on cytokine-induced proliferation in C6 
cells. Cells were cultured for 48 hours wi th or without TNF-a (100 
U / m l ) or LIF (1 ng/ml) and in the presence of various concentrations 
of nifedipine. PH]-thymidine incorporation was estimated as 
described before (Section 2.4). Values shown are means 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. Estimated IC50: TNF-a » 0.4 | iM, LIF » 1.8 ^M. 
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they effectively reduced the TNF-a- and LIF-induced C6 cell 
proliferation in a dose-dependent manner (Figs. 3.22-3.24). TNF-a 
and LIF were chosen as the former produced the highest while the 
latter the least proliferative effect in the presence of A23187 (Fig. 
3.21), although the maximum degree of inhibit ion varies w i th the 
compounds added. From the Figures 3.22, 3.23 and 3.24, i t was clear 
that the stimulatory effect of TNF-a was more sensitive to these three 
channel blockers, and complete or almost complete inhibit ion was 
observed w i th the LaCb (0.3 mM), verampil (10 ^M) and nifedipine (5 
fiM). On the other hand, the stimulatory effect of LIF was less 
sensitive to these calcium channel blockers (Figs 3.22-3.24). To further 
prove that calcium ions are involved in cytokine-induced 
proliferation, the effect of EGTA, a potent calcium chelator, was 
studied. Figure 3.25 showed that EGTA, at several concentrations, 
had no significant effect on PH]-thymidine incorporation in C6 cells. 
However, the cytokine-induced proliferation was significantly 
inhibited by this calcium chelator. In agreement wi th the results 
obtained wi th calcium channel blockers, the TNF-a-induced 
proliferative effect was more sensitive to EGTA (Fig. 3.25). 
3.3.4 The Involvement of Cyclic Nucleotides in Cytokine-induced C6 
Cell Proliferation 
Since the accumulation of cGMP in C6 cells can be regulated by 
cytokines (Simmons & Murphy, 1993; Vigne et aL, 1993), the effects of 
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Fig. 3.25 Effect of EGTA on cytokine-induced proliferation in C6 
cells. Cells were cultured for 48 hours wi th or without TNF-a (100 
U / m l ) or LIF (1 ng/ml) and in the presence of various concentrations 
of EGTA. PH]-thymidine incorporation was estimated as described 
before (Section 2.4). Values shown are means 土 standard error of 
quadruplicate wells. Estimated IC50: TNF-a » 26 fiM, LIF « 48 juM. 
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dbcAMP and/or dbcGMP on C6 cell proliferation were investigated. 
Moreover, i t is of particular interest to examine whether these two 
cyclic nucleotides mediate the proliferative effect of TNF-a or LPS on 
C6 cells. 
Figure 3.26 showed that both dbcAMP and dbcGMP can increase 
C6 cell proliferation and maximum stimulation was observed w i th 1 
m M of either cyclic nucleotide. The maximum stimulation observed 
w i th dbcAMP was 29 % which was slightly lower than that of 
dbcGMP (38 %). At 100 juM of dbcAMP, the incorporation of PH]-
thymldine was significantly inhibited, while significant stimulation 
was observed wi th the same concentration of dbcGMP. The reason 
for such difference is unclear. 
3.3.5 The Involvement of Nitric Oxide in Cytokine-induced C6 Cell 
proliferation 
Figure 3.26 has clearly shown that cyclic nucleotides, especially 
cGMP, may be involved in the signalling pathway of cytokine-
induced proliferation in C6 cells. Since cyclic GMP production is 
related to nitric oxide biosynthesis in C6 cells (Demerle-Pallardy et 
al" 1993; Simmons & Murphy, 1993; Vigne et al, 1993), i t is of interest 
to study the effects of sodium nitroprusside (SNP), an exogenous NO 
donor, and N^-methyl-L-arginine (NMA) and N^-nitro-L-arginine 
methyl ester (NAME), both being nitric oxide synthase (NOS) 
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Fig. 3.26 The effect of cyclic nucleotides on C6 cell proliferation. C6 
cells were cultured for 48 hours in medium or in the presence of 
indicated concentrations of dbcGMP or dbcAMP. DNA synthesis was 
estimated as described before (Section 2.4). Values shown are means 
士 standard error of quadruplicate wells. The X-axis was represented 
in a logarithmic scale. 
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inhibitors, on C6 cell proliferation. Contrary to expectation, SNP at 
concentrations of 10_7 - 10_4 M had no effect on PH]-thymidine 
incorporation, while higher concentrations were inhibitory (Fig. 3.27). 
On the other hand, dose-dependent inhibition of TNF-a- and LIF-
induced proliferation by both N〇S inhibitors--NMA and N A M E was 
observed (Figs. 3.28 and 3.29). The proliferative effects of TNF-a and 
LIF were decreased to 15 % and 5 % respectively by 400 ^ M of N M A , 
and to -3 % and 1 % respectively by 500 ^ M of NAME. However, at 
these concentrations N M A or NAME alone exerted only a slight 
effect (< 10 % inhibition or stimulation) on C6 cell proliferation (Figs. 
3.28-3.29). 
To assess the effects of various cytokines on NOS activity in C6 
cells, nitrite accumulation in the cell culture media was determined 
as described by Section 2.8.2. When C6 glioma cells were incubated 
w i th various cytokines, including 500 U / m l TNF-a, 5 n g / m l LIF and 
1 n g / m l IL - la or p, for three days, the increases in nitrite 
concentration were found to be 41 %, 38 % , 50 % and 51 % in the 
presence of TNF-a, LIF, IL - la and IL-ip, respectively (Figure 3.30) 
when compared to that of the control cells. 
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Fig. 3.27 The effect of SNP on C6 cell proliferation. C6 cells were 
cultured for 48 hours in presence or absence of various 
concentrations of SNP. PH]-thymidine incorporation was estimated 
as described before and % Inhibition = 100 x (CPMcontroi -
CPMsampie)/CPMcontroi (Section 2.4). The amount of PH]-thymidine 
incorporation was 60023 土 889.84 cpm/well. Values shown are means 
土 standard error of quadruplicate wells. The X-axis was represented 
in a logarithmic scale. 
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Fig. 3.28 Effect of N M A on cytokine-induced C6 cell proliferation. 
C6 cells were cultured for 48 hours in the presence or absence of the 
TNF-a (100 U /m l ) or LIF (1 ng/ml), wi th or without NMA. PH]-
thymidine incorporation was determined as described before (Section 
2.4). Values shown are means 士 standard error of quadruplicate 
wells. The X-axis was represented in a logarithmic scale. Estimated 
I C 5 0 : TNF-a « 208 ^iM, LIF « 8 ^M. 
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Fig. 3.29 Effect of NAME on cytokine-induced C6 cell proliferation. 
C6 cells were cultured for 48 hours in the presence or absence of the 
TNF-a (100 U / m l ) or LIF (1 ng/ml) , w i th or without NAME. PH]-
thymidine incorporation was determined as described before (Section 
2.4). Values shown are means 士 standard error of quadruplicate 
wells. The X-axis was represented in a logarithmic scale. Estimated 
ICso： TNF-a «15 ^M, LIF » 7 ^M. 
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Fig. 3.30 Effects of various cytokines on nitrite production in C6 
cells. C6 cells were incubated with the indicated cytokine for three 
days, and the nitrite formed in the culture media was determined 
using the Griess reagent as described in Section 2.8.2. Values shown 
are means 土 standard error of quadruplicate wells. * P < 0.05 
compared wi th control by Student's t test. 
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3.3.6 The Involvement of P-Adrenergic Receptor in Cytokine-induced 
C6 Cell Proliferation 
Since astrocytes are known to express P-adrenergic receptors on 
their surfaces (Mantyh et al., 1995), the effects of isoproterenol, a p-
adrenergic agonist, and propranolol, an antagonist of P-adrenergic 
receptor, on the proliferation of C6 cells were also investigated. It 
was found that the addition of 1 j jM of isoproterenol alone caused a 
30 % increase in PH]-thymidine incorporation in C6 cells (Fig. 3.31). 
On the other hand, propranolol at concentrations varying f rom 0.4 to 
25 | jM had no significant effect on the PH]-thymidine incorporation 
(Fig. 3.31). The stimulatory effect of isoproterenol was not affected by 
concentrations of < 10 jj,M of propranolol, but greatly reduced to 
below the control level wi th 25 juM of propranolol. Interestingly 
enough, 25 j jM propranolol also greatly reduced the stimulatory 
effect of TNF-a-induced PH]-thymidine incorporation in C6 cells 
(Fig. 3.32). The mechanism involved, however, is unclear at present. 
Further experiments are needed to confirm the involvement of p_ 
adrenergic receptor in cytokine-induced C6 cell proliferation. 
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Fig. 3.31 Effects of isoproterenol and propranolol on C6 cell 
proliferation. C6 cells were cultured for 48 hours in presence or 
absence of 1 fxM isoproterenol, plus various concentrations of 
propranolol. PH]-thymidine incorporation was estimated as 
described before (Section 2.4). Values shown are means 土 standard 
error of quadruplicate wells. The X-axis was represented in a 
logarithmic scale. 
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Fig. 3.32 The inhibit ion of TNF-a-induced C6 cell proliferation by 
propranolol. C6 cells were cultured for 48 hours in medium or in the 
presence of 10 or 100 U / m l TNF-a, plus various concentrations of 
propranolol. D N A synthesis was estimated as described before 
(Section 2.4). Values shown are means 士 standard error of 
quadruplicate wells. The X-axis was represented in a logarithmic 
scale. 
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Chapter 4 DISCUSSION AND CONCLUSIONS 
Results of the present study indicated that TNF-a, IL - la , IL- lp 
and LIF stimulate PH]-thymidine incorporation in C6 cells, in a dose-
and time-dependent manner. Not only was DNA synthesis increased 
but the growth of the C6 cells was also markedly enhanced by these 
cytokines. In addition, the present work demonstrated that LPS also 
stimulates proliferation of C6 cells (Fig. 3.5). LPS is known to be a 
potent cytokine inducer (Lee et al； 1993b), thus its effect may be via 
the cytokine(s) produced. These findings are in agreement w i th 
reports that TNF-a and IL-1 stimulate proliferation of astrocytes, both 
in vivo and in vitro (Giulian & Lachman, 1985; Selmaj et aL, 1990), as 
wel l as in rat C6 glioma cells (Munoz-Fernandez et al., 1991; Munoz-
Fernandez & Fresno, 1993). The morphological studies showed that 
neither TNF-a nor LIF caused any significant changes in the 
cytokine-treated cells (Figs. 3.7-3.8). The observation wi th TNF-a is in 
agreement wi th that reported by Munoz-Fernandez et al. (1991). C6 
cells are known to express both the astrocytic and oligodendritic 
phenotypes (Brodie & Vernadakis, 1991; Parker et al" 1980; 
Vernadakis et al" 1991). Our studies with GFAP antibody showed 
that over 90 % (Figs. 3.9) of the untreated C6 cell or C6 cells exposed 
to TNF-a for 48 hours were GFAP positive. Since GFAP is a marker 
protein for astrocytes (Eng et aL, 1971), the results suggest that the 
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cells used in the present study were mainly astrocytic. This finding 
may explain why TNF-a was mitogenic for astrocytes but caused 
damages to myelin and oligodendrocytes in vitro (Selmaj & Raine, 
1988, Selmaj et al； 1990). The proliferative effect observed suggest 
that cytokines, including TNF-a, LIF, IL - la and IL- ip, could play an 
important role during nerve tissue regeneration by stimulating the 
proliferation of glial cells as an autocrine growth factor and inducing 
differentiation of neurons as a neurotrophic factor. Since glial cells 
play an important role in guiding developing neurons (Rakic, 1971a 
and b), i t is possible that cytokines may influence neuron 
development. 
Primary and murine astrocytes can secrete IL-6 in response to a 
variety of stimuli, including virus, IL-1, TNF-a, IFN-y, LPS and 
calcium ionophore (Benveniste et al., 1990; Frei et al, 1989; Lieberman 
et al, 1989; Norris et al, 1994). Astrocytoma cells are known to 
express specific high-affinity receptors for IL-6 (Taga et al, 1987), and 
that this cytokine has a mitogenic effect on astrocytes (Selmaj et al,, 
1990). It is possible that the proliferative effect of TNF-a and other 
cytokines tested is mediated by the IL-6 produced upon stimulation 
w i th these cytokines. However, this possibility seems rather unlikely 
as no proliferative effect of IL-6 on C6 cells was observed. This notion 
is further supported by the observation that IL-6 was less potent that 
TNF-a and IFN-y in requiring much higher doses of up to 1,000 U / m l 
to reach maximum stimulation of thymidine incorporation in glial 
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cells (Munoz-Fernandez & ]Fresno, 1993). Receptors for LIF have not 
been reported on C6 cells, thus it is not known if this cytokine 
exerted its action by binding to its, or related, receptors. In this 
connection, i t is interesting to note that the LIF receptor has a 
significant sequence homology to the p subunit of IL-6 receptor 
(Gearing et al, 1991). As TNF-a also induces the secretion of 
granulocyte-colony stimulating factor and granulocyte-macrophage 
colony stimulating factors in astrocytes (Malipiero et al" 1990), the 
possible role of these two colony-stimulating factors in mediating the 
proliferative effect of TNF-a and other cytokines on C6 cells cannot 
be excluded from the present study and is currently under 
investigation in our laboratory. 
The data showed that LIF was inhibitory to C6 cell proliferation 
at 10 ng/mI , while lower concentrations of LIF were found to be 
stimulatory (Fig. 3.2). This differential effect of cytokine on glial cell 
proliferation had been reported in studies wi th IL-4, which affected 
cell proliferation in a similar fashion (Brodie & Goldreich, 1994). The 
reason for the stimulatory and inhibitory effects of these cytokines in 
C6 cells is unclear at present. In view of the fact that multiple 
receptors of different affinities for various cytokines exist in other 
cells (Miyajima et al, 1992), the biphasic effects of these cytokines 
may be due to the possibility that different cytokine concentrations 
affect interactions between the cytokine with its receptors of different 
affinities. This possibility is supported by binding studies which 
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showed the existence of high and low-affinity IL-4 receptors and the 
presence of both 55 kD and 75 kD TNF receptors in certain blood 
cells (Barna et al, 1992; Foxwell et al, 1989). 
In the present study, i t was found that the proliferative effects 
of TNF-a and LIF required a relatively short exposure time to these 
cytokines. It seems reasonable to speculate that receptors for these 
two cytokines already exist on the cell surface. More, since the 
proliferative effects of TNF-a and IL - la or p were additive rather 
than synergistic (data not shown), it is possible that these cytokines 
caused proliferation by affecting a (some) common signalling 
pathway(s) in C6 glioma cells. This thought seems more likely than 
the action of different cytokines on common receptors as selective 
receptors for various cytokines had been demonstrated (Barna et al,, 
1992; Benveniste et al, 1990; Gearing et al” 1991; and Selmaj et al, 
1990). 
Our study demonstrated that both TNF-a- and LIF-induced 
proliferation in C6 cells involve protein kinase C (PKC) (Figs. 3.10-
3.16), Ca2+ (Figs. 3.21-3.25) and tyrosine kinase (Figs. 3.17-3.20). The 
involvement of PKC mediating the action of TNF-a was 
demonstrated by observations that potent PKC inhibitors, Ro31-8220, 
staurosporine and calphostin C (Gescher, 1992), inhibited both the 
TNF-a- and LIF-stimulated proliferation in C6 cells (Fig. 3.11-3.13); 
whereas PKC activators, PMA and PDA, induced proliferation (Fig. 
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3.10). In addition, the proliferative effects of PMA and PDA were also 
blocked by the three PKC inhibitors tested (Figs. 3.14-3.16). This 
finding is supported by the recent reports that TNF-a and IL- lp 
activated PKC in cultured rat astrocytes (Norris et al, 1994), and that 
astrocyte proliferation is regulated by PKC (Bhat, 1989; Honegger, 
1986; Sawada et al, 1993). However, our f inding is different f rom that 
of Munoz-Fernandez & Fresno (1993), who reported that the 
proliferative effect of TNF-a and IFN-y in C6 cells was unaffected by 
H7, the only PKC inhibitor tested in their study. The lack of effect of 
H7 in their report may be due to the different potencies of various 
PKC inhibitors on different PKC isozymes (Gescher, 1992). In fact, we 
have found that Ro31-8220, a cogener of staurosporine, reduced the 
PMA inhibitory action on C-type natriuetic peptide-induced cGMP 
formation in C6 cells, while H7 was ineffective (Tsang, D. et al, 
unpublished observation). 
Since some PKC isoforms are calcium-dependent (Berridge, 
1993), the effects of A23187, a calcium ionophore, as well as some 
calcium channel blockers on cytokine-induced C6 cell proliferation 
were investigated. A23187 alone stimulated C6 cell proliferation (Fig. 
3.21); and in the presence of a sub-optimal dose of cytokines, such as 
10 U / m l of TNF-a, 0.1 ng /m l of LIF, 5 pg /m l of IL - la and 1 p g / m l of 
IL- ip, A23187 further enhanced the proliferation induced by these 
cytokines. The involvement of calcium in mediating the proliferative 
effects of TNF-a and LIF is further supported by observations that 
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blockers of calcium influx--LaCl3, verampil and nifedipine, inhibited 
the proliferative effects of these two cytokines in a concentration-
dependent manner (Figs. 3.22-3.24). In addition, EGTA, a Ca】+ 
chelator, also has similar inhibitory action on the cytokine-induced 
C6 cell proliferation (Fig. 3.25). The finding that Ca2+ is involved in 
the proliferative action of cytokines agrees wi th reports that cytosolic 
calcium is a key messenger in controlling many cellular processes, 
including gene transcription and programmed cell death (Nicotera et 
flZ., 1992; Petersen et al； 1994). The mechanism by which Ca2+ 
stimulated proliferation in C6 cells is unclear at present. As certain 
neurotransmitters, e.g., glutamate, are known to exert their effects by 
affecting ion channels and/or transporters (Frazer et al； 1990; Meyer 
& Mil ler, 1990), i t is conceivable that TNF-a may affect Ca2+ fluxes in 
C6 cells. This reasoning is supported by our findings that the 
cytokine-induced proliferative effect was inhibited by some selective 
calcium channel blockers, LaCl3, verampil and nifedipine (Figs. 3.22-
3.24). Another possibility is due to the intrinsic channel-formation 
property of TNF-a. It has been shown that TNF-a can insert into the 
hydrocarbon core of phospholipid bilayers (Baldwin et al., 1988). 
Moreover, TNF-a has been reported to form pH-dependent, voltage-
dependent, ion-permeable channels in planar l ip id bilayer 
membranes and increase the sodium permeability of human U937 
histiocytic lymphoma cells (Kagan et al； 1992). As A23187 is known 
to activate PKC, and that some PKC isoforms are calcium-dependent 
(Berridge, 1993), thus, it is quite possible that the action of Ca2+ is 
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mediated by activating PKC. However, this idea requires further 
testing w i th C6 cells. In view of the fact that the products produced 
upon the hydrolysis of phosphatidyl inositol 4, 5 bisphosphate by 
phospholipase C can activate PKC and mobilize calcium, the present 
findings do not allow us to discern whether calcium mobilization or 
activation of PKC is the primary signal transducing pathway 
mediating the proliferative effect of the cytokines studied. As A23187 
has been shown to enhance phospholipase A2 activity in pulmonary 
arterial smooth cells (Chakraborti et al, 1991), and that IL- lp induced 
phospholipase A2 activity in C6 cells, the involvement of 
phospholipase A2 in mediating the proliferative effects of cytokines 
in C6 cells is certainly worthy of serious consideration. This study is 
currently under close examination in our laboratory. 
Since tyrosine kinase is a well known second messenger in 
cytokines function (Stahl & Yancopoulos, 1993), its involvement in 
cell proliferation was also examined in this project. It was found that 
C6 cell proliferation induced by TNF-a and LIF was sensitive to the 
presence of the selective tyrosine kinase inhibitors, herbimycin A and 
tyrphostin (Bianchi et al； 1995; Feinstein et al, 1994a). The mechanism 
whereby TNF-a- and LIF-induced cell proliferation in C6 cells 
remains to be elucidated. In this connection it is interesting to note 
that the activity of nitric oxide synthase could be enhanced by LPS, or 
the combinations of IFN-y, IL-lp and TNF-a, and this activation was 
mediated by the tyrosine kinase pathway(Feinstein et al； 1994a and 
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b). In the present study, i t was found that the two tyrosine kinase 
inhibitors were able to block the proliferative effect of PMA and 
PDA. This would suggest that in the cytokine-induced proliferation 
signal cascade the tyrosine kinase activation may be located down-
stream to that of PKC activation. 
As mentioned above, Feinstein et al (1994a and b) reported that 
tyrosine kinase was involved in the expression of nitric oxide 
synthase in glial cells. Moreover, it was observed that high 
concentrations of N^-monomethyl-L-arginine, an active nitric oxide 
synthase (NOS) inhibitor, but not NG-monomethyl-D-arginine, a 
stereoisomer without NOS inhibitory activity, reduced the cytokine-
induced growth of C6 cells (Munoz-Fernandez & Fresno, 1993). These 
observations suggest that nitric oxide may be involved in cytokine-
induced proliferation of C6 cells. The present study demonstrated 
that the nitric oxide synthase inhibitors, N<^-methyl-L-arginine and 
N^-nitro-L-arginine methyl ester (Knowles & Moncada, 1994), 
reduced the proliferative effect of TNF-a or LIF on C6 cells (Figs. 3.28 
and 3.29), while neither inhibitors alone affected the PH]-thymidine 
incorporation of the cells. However, the participation of nitridergic 
pathway in mediating cytokine-induced proliferation in C6 cells 
seems to be less important as it was recently reported that LPS alone 
was not a sufficient inducer, but rather the presence of cytokines was 
needed to stimulate NOS expression (Feinstein et al” 1994b). 
Moreover, the addition of TNF-a or IFN-y alone, but without LPS, 
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had no effect on NOS activity in C6 cells (Feinstein et aL, 1994b). 
Furthermore, Simmons and Murphy (1993) found that in C6 cells LPS 
and cytokine increased the production of cGMP, one of the primary 
products related to the signal transduction of nitric oxide (Synder & 
Bredt, 1992) and this stimulatory action had a r igid dependency on 
the presence of L-arginine. Since no extra L-arginine (except the small 
amount present in the culture medium) was added in our 
experiments, this would suggest that the nitridergic pathway is less 
important in mediating the cytokine-induced proliferation in C6 cells. 
Even in the presence of added L-arginine, neither TNF-a alone nor a 
combination of IFN-y and IL- lp caused any detectable increase in 
cGMP production in C6 cells unti l 4 hours after the addition of 
cytokines (Simmons and Murphy, 1993). In our study, however, 
significant proliferative effect of TNF-a was observed after 60 
minutes exposure to TNF-a (Fig. 3.4) Moreover, the exogenous nitric 
oxide donor, sodium nitroprusside at non-cytotoxic concentrations, 
d id not show any proliferative effect on C6 glioma cells (Fig. 3.27). 
Though the nitric oxide formation was induced by cytokines 
including TNF-a, LIF, IL - la and IL-ip (Fig. 3.30), the increase was 
much lower than the reported data of Munoz-Fernandez & Fresno 
(1993). The reason for the discrepancy is unclear, but may be due to 
the higher concentrations of cytokines and longer time of incubation 
used in their proliferation assays. In short, i t seems reasonable to 
conclude that the nitridergic pathway plays a necessary but less 
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important role compared to other transducing pathways, in 
mediating the proliferative effect of cytokines in C6 cells. 
Recently, i t was reported that cGMP production in glial cells 
was induced and regulated by cytokines (Simmons & Murphy, 1992 
and 1993; Vigne et al； 1993). These authors found that the cytokine-
induced cGMP production had a rigid dependency on L-arginine, 
and was NO-dependent. However, we were unable to show the 
increase in cGMP production by TNF-a in several attempts (data not 
shown). The reason may be due to the lack of extra addition of L-
arginine in our studies. On the other hand, in agreement w i th the 
reports of Simmons & Murphy (1992 and 1993), we found that cGMP 
as wel l as cAMP increased PH]-thymidine incorporation in C6 cells 
(Fig. 3.26). The mechanism through which cGMP increased pH]-
thymidine incorporation in C6 cells remains unclear. It is possible 
that the action of cGMP may involve changes in calcium fluxes and 
phospholipases as it had been shown that cGMP could regulate 
calcium fluxes and induce the formation of inositol phosphates in 
astroglia (Fumkawa et al” 1986; Hirata et al, 1990). 
In summary, the present study showed that a number of 
cytokines, including TNF-a, LIF, IL- la and IL-lp, stimulated pH]-
thymidine incorporation in C6 glioma cells. The reason why so many 
cytokines can stimulate C6 cell proliferation is unclear, i t may be that 
these cytokines after binding to their respective receptors trigger the 
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same signal transducers in C6 cells, and this would explain the 
redundant biological effects of cytokines (Meager, 1990). The 
proliferative effect of these cytokines on C6 cells suggests that 
cytokines produced by glial cells could play an important role in the 
nervous system in response to trauma and inflammation. Similar 
conclusions have been reached by other investigators in their studies 
w i th cultured astrocytes (Chung & Benveniste, 1990; Eddleston & 
Mucke, 1993; Kasahara et al 1990). In addition, astrocytes are known 
to synthesize and secrete NGF and other neurotrophic factors which 
play an important role in the survival, growth and differentiation of 
neurons in the CNS (Furukawa et al, 1986). Recent studies indicate 
that NGF synthesis can be regulated by a variety of growth factors 
and cytokines (Yoshida & Gage, 1992), and can be induced in reactive 
astrocytes during brain injury (Goedert et al, 1986). Our finding that 
various proinflammatory cytokines can stimulate C6 cell proliferation 
indicates that these and possibly other cytokines may provide 
neurotrophic effect in the CNS during instances of injury and 
inflammatory events. In addition to these pathological implications, 
increasing evidence supports the ideas that cytokines coordinate 
migration and proliferation of glial cells, as well as regulate neuronal 
network formation during normal development of the nervous 
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